Fluid transfer devices and methods of use

Information

  • Patent Grant
  • 11883361
  • Patent Number
    11,883,361
  • Date Filed
    Friday, January 21, 2022
    2 years ago
  • Date Issued
    Tuesday, January 30, 2024
    11 months ago
Abstract
Systems and methods for the transfer of medical fluid are provided. A medical fluid transfer system may comprise a pump configured to transfer fluid through a tube assembly having a first connector configured to couple to a source container and a second connector configured to couple to a target container. The medical fluid transfer system may also comprise a destination sensor configured to output information about the target container. The medical fluid transfer system may further comprise a control system configured to operate the pump based on an operational setting associated with fluid volume; receive measurement data representing a measurement of the target container by the destination sensor, and adjust the operational setting based on an observed volume of fluid transferred to the target container.
Description
INCORPORATION BY REFERENCE

U.S. Pat. No. 8,522,832 (the “'832 Patent”), titled “FLUID TRANSFER DEVICES AND METHODS OF USE,” filed on Jul. 28, 2010 as U.S. patent application Ser. No. 12/845,548, and granted on Sep. 3, 2013, is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Pat. No. 5,685,866 (the “'866 Patent”), titled “MEDICAL VALVE AND METHOD OF USE,” filed on Nov. 4, 1994 as U.S. patent application Ser. No. 08/334,846, and granted on Nov. 11, 1997, is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Pat. No. 7,998,134 (the “'134 Patent”), titled “MEDICAL CONNECTOR WITH CLOSEABLE MALE LUER,” filed on May 8, 2008 as U.S. patent application Ser. No. 12/117,568, and granted on Aug. 16, 2011, is incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Pat. No. 8,409,164 (the “'164 Patent”), titled “ANTI-REFLUX VIAL ADAPTORS,” filed on Aug. 19, 2009 as U.S. patent application Ser. No. 12/543,776, and granted on Apr. 2, 2013, is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Provisional Patent Application No. 61/557,793 (the “'793 application”), filed Nov. 9, 2011, and titled “MEDICAL CONNECTORS WITH FLUID-RESISTANT MATING INTERFACES,” is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


PCT Patent Application No. PCT/US2012/054289, filed Sep. 7, 2012, and titled “MEDICAL CONNECTORS WITH FLUID-RESISTANT MATING INTERFACES,” is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Pat. No. 8,758,306 (the “'306 Patent”), titled “MEDICAL CONNECTORS AND METHODS OF USE,” filed on May 12, 2011 as U.S. patent application Ser. No. 13/106,781, and granted on Jun. 24, 2014, is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


U.S. Pat. No. 9,883,987 (the “'987 Patent”), titled “FLUID TRANSFER DEVICES AND METHODS OF USE,” filed on Jun. 20, 2014 as U.S. patent application Ser. No. 14/310,942, and granted on Feb. 6, 2018, is hereby incorporated by reference in its entirety and made a part of this specification for all that it discloses.


BACKGROUND
Field of the Disclosure

Some embodiments of the invention relate generally to devices and methods for transferring fluid and specifically to devices and methods for transferring medical fluids.


Description of the Related Art

In some circumstances it can be desirable to transfer one or more fluids between containers. In the medical field, it is often desirable to dispense fluids in precise amounts and to store and to transport potentially dangerous fluids. Current fluid transfer devices and methods in the medical field suffer from various drawbacks, including high cost, low efficiency, intensive labor demands, and excessive fluid or vapor leakage. Some embodiments disclosed herein overcome one or more of these disadvantages.


SUMMARY OF SOME EMBODIMENTS

Some embodiments disclosed herein relate to systems and methods for transferring fluid from source containers to target containers.


In some embodiments a medical fluid transfer system is provided. The medical fluid transfer system may comprise a pump configured to transfer fluid through a tube assembly having a first connector configured to couple to a source container and a second connector configured to couple to a target container. The medical fluid transfer system may also comprise a destination sensor configured to output information about the target container. The medical fluid transfer system may further comprise a control system. The control system may be configured to: receive an instruction to transfer a desired volume of a medical fluid to the target container; operate the pump based on the instruction and an operational setting associated with fluid volume; receive measurement data representing a measurement of the target container by the destination sensor (e.g., the weight of the target container after transfer of medical fluid to the target container); determine a difference between a transferred volume of the medical fluid and the desired volume of the medical fluid based at least partly on the measurement data and a fluid property of the medical fluid (e.g., specific gravity of the medical fluid); adjust the operational setting based on the difference; and operate the pump based on the operational setting that has been adjusted.


In some embodiments, the control system comprises a user interface, and the measurement data is received by the control system via the user interface. In some embodiments, the control system comprises a first communication interface, the destination sensor comprises a second communication interface, the destination sensor transmits the measurement data via the second interface, and the measurement data is received by the control system via the first communication interface. In some embodiments, the control system determines the transferred volume of medical fluid based on the specific gravity of the medical fluid and the weight of the target container. In some embodiments, the pump is a peristaltic pump comprising a rotor with one or more lobes. In some embodiments, the operational setting indicates a quantity of rotations that the rotor is to be rotated for transfer of one or more volumetric units of the medical fluid. In some embodiments, a plane of rotation of the rotor is substantially orthogonal to a direction of gravity during operation of the peristaltic pump. In some embodiments, the control system is further configured to manage a batch transfer operation in which the control system operates the pump to transfer the desired volume of the medical fluid to each of a plurality of target containers. In some embodiments, the control system is further configured to delay a subsequent segment of the batch transfer operation for a predetermined time interval after completion of a prior segment of the batch transfer operation.





BRIEF DESCRIPTION OF THE DRAWINGS

Certain embodiments of the invention will now be discussed in detail with reference to the following figures. These figures are provided for illustrative purposes only, and the embodiments are not limited to the subject matter illustrated in the figures.



FIG. 1A schematically shows an example embodiment of an automated system for transferring fluid.



FIG. 1B schematically shows another example embodiment of an automated system for transferring fluid.



FIG. 2 is a view of an example embodiment of an automated system for transferring fluid.



FIG. 3 is a front view of the system of FIG. 2.



FIG. 4 is a back view of the system of FIG. 2.



FIG. 5 is a perspective view of an example embodiment of a fluidics assembly that can be used to transfer fluid.



FIG. 6 is an exploded view of the fluidics assembly of FIG. 5.



FIGS. 7, 8, and 9 illustrate usage of an embodiment of a peristaltic pump.



FIG. 10 is a flow diagram of an example embodiment of a method for using an automated system for transferring fluid.



FIG. 11 is a view of another example embodiment of an automated system for transferring fluid.



FIG. 12 is a top view of the system of FIG. 11 during installation of a fluidics assembly.



FIG. 13 schematically shows components of the system of FIG. 11.



FIG. 14 is a view of user interfaces for managing the transfer of fluid using the system of FIG. 11.



FIG. 15 is a flow diagram of an example embodiment of a method for calibrating an automated system for transferring fluid.



FIG. 16 is a view of user interfaces for managing the calibration of the system of FIG. 11.



FIG. 17 is a flow diagram of an example embodiment of batch fluid transfer method with periodic verification.



FIG. 18 is a view of user interfaces for managing the batch transfer of fluid with period verification using the system of FIG. 11.





DETAILED DESCRIPTION OF SOME EXAMPLE EMBODIMENTS

The following detailed description is now directed to certain specific example embodiments of the disclosure. In this description, reference is made to the drawings wherein like parts are designated with like numerals throughout the description and the drawings.


In many circumstances fluid is transferred from a source container to a target container. In some instances, it can be desirable to transfer precise amounts of a fluid, such as a medication, into the target container. For example, in some embodiments a medication can be stored in a vial or other container, and a precise dosage amount of the medication can be extracted and transferred to a target device so that the dosage amount can be delivered to a patient. In some embodiments, fluid from multiple source containers can be combined, or compounded, into a single target container. For example, in some embodiments a mixture of medications can be created in the target container, or a concentrated medication can be combined with a diluent in the target container. To achieve the desired proportions of fluids, it can be desirable to precisely measure the amounts of fluids transferred into the target container. Also, precisely measuring the amount of fluid transferred from the source container to the target container can reduce the amount of fluid wasted (e.g., when more fluid than necessary is withdrawn from the source container). Reduction of waste is desirable because, for example, in some instances the fluid being transferred can be expensive.


Some embodiments disclosed herein provide fluid transfer devices for transferring precise amounts of fluid from one or more source containers into one or more target containers.


In some embodiments, it can be desirable to transfer fluids from a source container to a target container using a sealed system. In some embodiments, exposing the fluid to ambient air can allow contaminants to enter the fluid or cause an undesirable reaction with the fluid. Some medications (e.g., chemotherapy medications) can be harmful to an unintended recipient. Therefore, it can be desirable to prevent or reduce exposure of the fluid being transferred to the ambient air or area outside the fluid transfer system. In some embodiments, a fluid transfer system that prevents or reduces exposure of the fluid to the area outside the fluid transfer system can render other expensive equipment (e.g., a clean room) unnecessary, thereby reducing the cost associated with transferring the fluids.


Some embodiments disclosed herein provide a fluid transfer device for transferring fluid while preventing, reducing, or minimizing the amount of contact the fluid has with the ambient air or area outside the fluid transfer system.



FIG. 1A schematically shows an embodiment of an automated fluid transfer system 1200. The system 1200 comprises one or more fluid transfer stations 1218a-b, a destination sensor, such as an end volume sensor or a weight sensor 1222, and a controller 1204. Although in the embodiment shown, the components are all contained within the housing 1202, a variety of other configurations are possible. For example, the system 1200 can include one or more housings 1202 enclosing components of the various systems. In some embodiments, each component grouping can have a separate housing (as illustrated by the dashed lines within the housing 1202). In some embodiments the controller 1204 can be contained within the same housing as the first fluid transfer station 1218a. In some embodiments there is a single fluid transfer station 1218a. In some embodiments there can be a plurality (e.g., a first and a second) of fluid transfer stations 1218a-b. In some embodiments the destination sensor 1222 can be in a different housing than the fluid transfer stations 1218a-b and the controller 1204. In some embodiments, the controller 1204 can be external to the housing 1202, and can be, for example contained within a second housing, which may also contain the user interface 1208.


The system 1200 has a controller 1204 and a memory module 1206. The controller 1204 can be configured to control the operation and functions of the fluid transfer stations 1218a-b and the destination sensor 1222. The system 1200 can also include a user interface 1208, which can be, for example, external to the housing 1202. The user interface 1208 can also be integrated into the housing 1202 in some cases. The user interface 1208 can include, for example, a display, a keypad, and/or a touch screen display. The user interface 1208 can be configured to receive instructions from the user, for example, regarding the amounts of fluid to be transferred and the types of fluids to be transferred. The user interface can also be configured to provide information to the user, such as error messages, alerts, or instructions (e.g., to replace an empty vial). In some embodiments, the system 1200 can include a communication interface 1210 configured to receive information (e.g., instructions) from a remote source such as an external controller 1212, a terminal (such as a computer) 1214, or an automated management system (such as a hospital information system (HIS)) 1216, etc. In some embodiments, the communication interface can also send information (e.g., results or alerts) to the remote source. The communication interface can include one or more connection types and can be configured to allow connectivity to multiple remote sources at once. In some embodiments, the system 1200 does not include a communication interface 1210 and does not communicate with a remote source.


The destination sensor 1222 can include a communication interface 1221 that can communicate with the controller 1204. In some embodiments a weight sensor 1222 can communicate with the controller using wireless communication. In some embodiments a weight sensor 1222 can be physically connected to the controller 1204 using a standard communication interface (e.g., RS232, USB, etc.). The controller 1204 can receive information (e.g., measurements, current state of operation, etc.) and provide commands (e.g., zeroing the weight sensor) to the weight sensor 1220 through the communication interface 1221. In some embodiments the weight sensor 1222 can include a user interface 1223. The user interface can provide a visual indication of weight, and other information. In some embodiments the weight sensor 1222 can receive commands or instructions through the user interface 1223 from a user.


The destination sensor 1222 is used to determine the amount of fluid transferred from the source container 1220a-b to the target container 1224. The destination sensor 1222 outputs the weight of the fluid transferred to the target container to the controller 1204. Prior to transferring fluid, the scale can be programmatically zeroed in order to compensate for the weight of the target container 1224. For example, a base weight can be assigned as “zero” fluid weight (i.e., equivalent to the weight of the inherent scale weight and/or equivalent to the inherent scale weight plus a first fluid weight, and/or equivalent to the weight of the target container). The scale can then determine the relative weight of the fluid transferred to the target container 1224 beyond the base weight.


In some embodiments, the destination sensor 1222 is a scale that is capable of receiving weight information and electronically providing the information to the controller 1204. The scale can be located in a separate housing 1202. In some embodiments, the scale can have a substantially flat weighing surface for the target container. In some embodiments (not illustrated) the scale can be a hanging scale.


In some embodiments, the fluid transfer station can include a positive displacement pump, such as a peristaltic pump, 1240a-b, a motor 1242a-b and a fluidics assembly. The positive displacement pump 1240a-b can be used to pump fluid from a source container 1220a-b to a target container 1224. The fluid is transferred via a hose 1228a-b fitted inside a pump mounting interface 1244a-b. A rotor with a number of lobes rotates and compresses the hose 1228a-b progressively along an advancing portion of the hose. As the lobe passes a particular portion of hose, such portion of hose rebounds to substantially its original shape and internal volume. As the rotor turns, the part of hose 1228a-b under compression is pinched, thus, displacing fluid and forcing the fluid to move forward through the tube. The speed of the rotation of the rotor, the number of lobes, and the material properties of the hose influence the flow rate of the fluid through the system. The flow rate of the fluid transfer can be controlled by varying the speed of the pump 1240a-b. The motor 1242a-b operating the pump 1240a-b can run at variable speeds. The peristaltic pump 1240a-b can be configured to operate at a low pressure. The pressure generated by the pump 1240a-b can be sufficiently low, such that it is below a threshold at which the connector 1230a-b will not leak if the pump is operating and the connector 1230a-b is not connected to the target container.


The operations of the pump can be controlled by the controller 1204. In some embodiments, the housing 1202 incorporating the pump can have a touch screen that allows commands to be provided to the controller 1204. For example, a user can instruct the pump to transfer a specific amount of fluid to the target container. In some embodiments the commands can be received from an external source such as a network computer. The controller 1204 can operate the pump at variable speeds by controlling the speed of the motor. The controller 1204 can control that rate at which the rotor is spinning, which, in turn, controls the fluid flow rate. In some embodiments, the computer can use an algorithm to reduce the speed of the motor as the amount of fluid approaches the desired amount of fluid in the target container in order to increase accuracy.


Each fluid transfer station 1218a-b can have a fluidics assembly that includes a first connector 1226a-b, a hose 1228a-b, and a second connector 1230a-b. The hose 1228a-b can be formed from a compressible material (e.g., silicone rubber, and other elastomeric materials). The hose 1228a-b is configured to be inserted within the mounting interface 1244a-b of the peristaltic pump 1240a-b (as illustrated by the dashed line) in order to facilitate the transfer of fluid between the source container 1220a-b and the target container 1224. Some embodiments can be assembled from different types or portions of hose. In some embodiments, the hose 1228a-b can be formed from a single material. In some embodiments, the hose is formed with an elastomeric portion and other portions formed from polymeric materials. The first and second connectors 1226a-b, 1230a-b are fixedly coupled to the hose 1228a-b at opposite ends and are not configured to be removable from the hose. The first connector 1226a-b is configured to connect to the source container 1220a-b. In some embodiments, one or more pairs of male and female fluid connectors configured to be attached to each other to selectively permit the passage of fluid between the source container 1220a-b and the target container 1224. The connectors can be detached or disconnected, for example, so that the target container 1224 can be removed once the fluid has been transferred. In some embodiments, the connectors can be configured to automatically close when disconnected from a corresponding connector, thereby preventing fluid from escaping when the connectors are detached. Thus, the fluid transfer system 1200 can be used to transfer fluid while retaining substantially entirely, or entirely, all of the fluid within the system, permitting the fluid transfer to occur in a substantially entirely, or entirely, closed system. The fluid transfer system 1200 can thereby reduce or eliminate the risk of injury, waste, or damage caused by liquid or vapor leakage when connecting and disconnecting the components of the fluid transfer system 1200.


Each transfer station 1218a-b can include a fluid source container 1220a-b, which can be, for example, a medical vial or other suitable container such as a bag, a bottle, or a vat, etc. Although many embodiments disclosed herein discuss using a vial as the source container, it will be understood the other containers can be used even when not specifically mentioned. In some embodiments, each of the source containers 1220a-b can contain a unique fluid, providing a variety of fluids that the user can select for transfer. In other embodiments, two or more of the source containers 1220a-b can contain the same fluid. In some embodiments, the source containers 1220a-b include bar codes that identify the types of fluid contained therein. The bar codes can be scanned by a bar code scanner 1205 that is in communication with the controller 1204 and/or the memory 1206 (e.g., via the communication interface 1210) so that the identities of the fluids contained by source containers 1220a-b can be stored within the memory module 1206. In some embodiments, the fluid transfer stations 1218a-b are configured to transfer precise amounts of fluid from source containers 1220a-b to a target container 1224, which can be, for example an IV bag. It will be understood that in various embodiments described herein, a different type of target container or destination container can be used instead of an IV bag (e.g., a syringe, a bottle, a vial, an elastomeric pump, etc.) even when not specifically mentioned.


In some embodiments, the system 1200 can include source adapters 1236a-b configured to receive the source containers 1220a-b and removably connect to the connectors 1226a-b. Thus, when a source container 1220a-c runs out of fluid, the empty source container 1220a-b and its corresponding adapter 1236a-b can be removed and replaced without requiring disengagement of the associated connector 1226a-b from the housing 1202. In some embodiments, source adapters 1236a-b can be omitted, and the source containers 1220a-b can be directly received by the connectors 1226a-b.


In some embodiments using two or more fluid transfer stations 1218a-b, the fluid transfer system 1200 can be used to transfer and combine individual fluids from the source containers 1220a-b to the target container 1224. The system 1200 can be used for compounding mixtures of fluids. For example, the system 1200 can be used to combine multiple medications together or to combine feeding fluids (e.g., water, dextrose, lipids, vitamins, minerals). The system 1200 can also be used to dilute a medication or other fluid to a desired concentration level. In some embodiments, a first fluid transfer station 1218a can include a concentrated medication or other fluid, and a second fluid transfer station 1218b can include saline or other diluent. The system 1200 can be configured to receive input (e.g., from a user or from a hospital information system) indicating a desired amount and concentration of medication, and the system 1200 can be configured to transfer the precise amounts of the concentrated medication and the diluent required to fill the source container 1224a with the desired amount and concentration of the medication. The system can calculate the amount that needs to be transferred from each fluid transfer station 1218. The operation can then be done serially by transferring a first fluid from the first transfer station 1218a and then separately transferring a second fluid from the second transfer station 1218b. In some embodiments, a technician can manually connect the first fluid transfer station 1218a, via connector 1230a, to the target container 1224. After the first fluid is transferred the connector 1230a is disconnected and second fluid transfer station is connected, via connector 1230b, to the target container 1224 to transfer the second fluid. In some embodiments, the system 1200 can include an actuator that is capable of automatically switching the connection of the target container 1224 between the fluid transfer stations 1218a-b. In some embodiments, the actuator can switch between different fluid sources at the same fluid transfer station. For example, the first fluid source can be a concentrated medication or other fluid, and a second fluid source can be saline or some other diluent.


In some embodiments, the system 1200 can include compatibility modules 1232a-b for permitting connections with approved connectors 1226a-b, and for preventing connectors other than approved connectors 1226a-b from being placed in communication with the system 1200. The compatibility modules can be, for example, a specifically shaped mounting feature (e.g., on the housing of the fluid transfer station) that is configured to interface with a corresponding portion of the connector 1226a-b, 1230a-b. In some embodiments, the compatibility modules 1232a-b can be one or more sensors configured to detect the presence of an approved connector 1226a-b or to align with a specific portion of the connector 1226a-b during operation.


In some embodiments the system 1200 can include sensors 1234a-b for detecting the presence of the target container 1224. Sensors 1234a-b can be in communication with the controller 1204 so as to prevent the system 1200 from attempting to transfer fluid when no target container 1224 is connected. A variety of sensor types can be used for sensors 1234a-b. For example, sensors 1234a-b can be weight sensors, sensor pads, infrared sensors, or other forms of electronic sensors. In some embodiments, the sensor 1234a-b can align with a substantially transparent portion of the connector 1226a-b to detect whether a valve on the connector 1226a-b leading to target container 1224a-b is open. If open, the sensor 1234a-b can send a signal to the controller 1204 so that fluid transfer is permitted. The sensors 1234a-b can be configured to align properly with only approved connectors 1226a-b so that the sensors 1234a-b do not allow fluid transfer if an unapproved connector is used. Thus, the sensors 1234a-b can be used as the compatibility modules 1232a-b in some embodiments.


The fluid transfer system 1200 can have many different configurations. For example, in some embodiments there is only a single fluid transfer station. In some embodiments, certain features shown in FIG. 1A can be omitted for some or all of the transfer stations. For example, in some embodiments, a fluid transfer station can have the sensors omitted because, for example, a particular peristaltic pump does not generate sufficient pressure to cause fluid to leak out the connector when a target container is not connected and the pump is running.



FIG. 1B illustrates an example embodiment of a fluid transfer system 1250 in a configuration that can have features similar to, or the same as, the example fluid transfer system 1200 shown in FIG. 1A. For example, the system 1250 may include one or more fluid transfer stations that each comprise a peristaltic pump 1240 and a motor 1242 to transfer fluid from a source container to a target container, as described in greater detail herein. The system 1250 has a controller 1204 that can be configured to control the operation and functions of one or more fluid transfer stations. The fluid transfer system 1250 can include one or more circuit boards, such as boards 1252 and 1254. The circuit boards 1252, 1254 may support the controller 1204 any of a variety of electronic components, such as any or all of the electronic components of the fluid transfer system 1200 shown in FIG. 1A, by providing power, communications, and the like.


The system 1250 can also include a user interface 1208, such as a display, a keypad, and/or a touch screen display. The user interface 1208 can be configured to receive instructions from the user, for example, regarding the amounts of fluid to be transferred and the types of fluids to be transferred. The user interface can also be configured to provide information to the user, such as error messages, alerts, or instructions (e.g., to replace an empty vial).


In some embodiments, the system 1250 can include a communication interface 1210 configured to receive information (e.g., instructions) from a remote source such as an external controller, a terminal (such as a computer), or an automated management system (such as an HIS), etc. In some embodiments, the communication interface 1210 can also send information (e.g., results or alerts) to the remote source. The communication interface 1210 can include one or more connection types and can be configured to allow connectivity to multiple remote sources at once. In some embodiments, the system 1250 does not include a communication interface 1210 and does not communicate with a remote source.


The fluid transfer system 1250 may also include a weight sensor 1222 to assist in evaluating the transfer of fluid to and/or from a container, such as a source container or target container. The fluid transfer system 1250 may also include a bar code scanner 1205 for input of data from medication containers, patient charts, or the like.


The fluid transfer system 1250 may include one or more components in addition to, or instead of, those of the fluid transfer system 1200. In some embodiments, as shown, the fluid transfer system 1250 may include a battery 1260 to provide primary power, or to provide backup power in the event of disconnection from—or otherwise loss of power from—a primary power source. The fluid transfer system 1250 may include a speaker 1262 to provide audible feedback, alerts, etc. The fluid transfer system 1250 may include a printer 1264 to print hard copies of information, such as labels for medication, barcodes, and the like. The fluid transfer system 1250 may include a pedal 1266 to provide input, such as start or stop commands. These components may be coupled to or otherwise in electronic communication with one or more circuit boards 1252, 1254.


The fluid transfer system 1250 can have many different configurations. For example, in some embodiments there is only a single fluid transfer station. In some embodiments, certain features shown in FIG. 1B can be omitted for some or all of the transfer stations.



FIG. 2 is an example embodiment of a fluid transfer system 1300, which can have features similar to, or the same as, the systems 1200 and/or 1250 described above or any other fluid transfer system described herein. FIG. 3 is a front view of the fluid transfer system 1300 and FIG. 4 is a back view of the fluid transfer system 1300. In FIGS. 3 and 4, certain features (i.e., the fluidics assembly) are omitted from view. The system 1300 can include a fluid transfer station 1318 and a weight sensor 1322.


The fluid transfer station 1318 includes a housing 1302, a peristaltic pump 1350, a motor (not shown), a user interface 1308, and a pole assembly 1342. The user interface 1308 can be incorporated into the housing. The user interface 1308 can include a touchscreen, a keypad, a display, or other suitable interface devices for providing information to a user and/or for providing input from the user to a controller (not shown).


As can be seen in FIG. 4, the fluid transfer station 1318 and the weight sensor 1322 can have communication interfaces 1310a-b. The communications interfaces 1310a-b can include one or more connection points to receive cables from one or more remote sources such as a remote terminal (e.g., a computer) or an automated management system (e.g., a hospital information system (HIS)). The fluid transfer station 1318 and the weight sensor 1322 have a communication link established between them, such as by cable 1312. In some embodiments the weight sensor 1322 and the fluid transfer station can establish a communication using wireless signal.


In some embodiments, the communication interfaces 1310a-b can be configured to provide a communication link between the system 1300 (i.e., the fluid transfer station and the weight sensor) and a remote location. The communication link can be provided by a wireless signal (e.g., using an antenna) or by one or more cables or a combination thereof. The communication link can make use of a network such as a WAN, a LAN, or the internet. In some embodiments, the communication interfaces 1310a-b can be configured to receive input (e.g., fluid transfer commands) from the remote location and/or can provide information (e.g., results or alerts) from the system to the remote location.


The fluid transfer station 1318 can be configured to transfer fluid from a vial 1320 to an IV bag 1324 using a peristaltic pump 1350. The fluid is transferred from the vial 1320 through a connector 1326, and into a hose assembly 1330. The peristaltic pump 1350 moves the fluid from the hose assembly 1330 through the connector 1328 and into the IV bag 1324. The operation of the peristaltic pump 1350 is controlled by the controller based on commands or information received from a user. An example of the fluidics assembly is described in additional detail below with additional reference to FIGS. 5 and 6. Operation of an embodiment of a peristaltic pump is described in additional detail below with reference to FIGS. 7 through 9.


The fluid transfer station 1318 can include a pole assembly 1342, which can be configured to hold fluid containers such as vials and fluid bags. A pole 1344 can extend upward from the housing 1302, and in some embodiments, the pole 1344 can be height adjustable and a thumb screw 1346 can be tightened to hold the pole 1344 in place. The thumb screw 1346 can be loosened to enable adjustment of the height of the pole 1344, and in some embodiments, the pole 1344 can be lowered into a recess formed in the housing 1302 that is configured to receive the pole 1344. the pole 1344 can be entirely, substantially entirely, or mostly withdrawn into the housing 1302 when the pole 1344 is not in use (e.g., during storage or transportation or when not needed to support fluid containers). One or more support modules 1348 can be attached to the pole 1344 and can be configured to support fluid containers. The support modules 1348 can include thumb screws so that the positions of the support modules 1348 on the pole 1344 can be adjustable, and/or so that the support modules 1348 can be removable from the pole 1344. In the illustrated embodiment, the support module 1348 can have one or more curved arms for supporting a fluid container such as vial 1320.


In some embodiments, the weight sensor can include a housing 1316, a user interface, and a weighing surface 1321. The user interface 1308 can be incorporated in the housing 1316. The user interface 1308 can provide a visual indication of weight, and other information. In some embodiments the weight sensor 1322 can receive commands or instructions through the user interface 1308 from a user. In some embodiments the weight sensor 1322 does not include a user interface 1308. The weighing surface 1321 is configured to provide a surface for the IV bag. The weighing surface 1321 can be sized so that the IV bag 1324 or other target container can be properly balanced and positioned on the weight sensor.


The weight sensor 1322 can provide information to (e.g., measurements, current state of operation, etc.) and receive commands (e.g., zeroing the weight sensor) from the fluid transfer station 1318 through the communication interface 1310b. The weight sensor 1322 is used to determine the amount of fluid transferred from the vial 1320 to the IV bag 1324.



FIG. 5 is a perspective view of a fluidics assembly 1339 that can be used with the fluid transfer station 1318. FIG. 6 is a perspective exploded view of the fluidics assembly 1339 shown in FIG. 5. The fluid assembly 1339 can be used to transfer precise amounts of fluid from a vial 1320 to an IV bag 1324. The fluidics assembly 1339 includes a vial 1320, a vial adapter 1352 configured to provide fluid communication with the fluid (e.g., chemotherapy drug or other medication) contained within the vial 1320 to a connector 1326, a tubing assembly 1330, a connector 1328, and the IV bag assembly 1324. In some embodiments, the fluidics assembly 1339 can be configured to allow the vial 1320 and vial adapter 1352 to be replaced (e.g., when the vial runs out of fluid) without replacing the connector 1326 or the tubing assembly 1330. In some embodiments, the vial adapter 1352 can be configured to allow air to enter the vial 1320 via the vial adapter 1352, thereby substantially equalizing pressure in the vial 1320 as fluid is drawn out.


A tubing or hose assembly 1330 can extend between the connector 1326 and the connector 1328. The tubing assembly includes first tube portions 1334, a second tube portion 1332, and tubing connectors 1336. The second tube portion 1332 is configured to be inserted within the peristaltic pump 1350. In some embodiments the second portion 1332 can be configured to be more flexible than the first portion 1334. In some embodiments the second tube portion 1332 can be configured to have a lower durometer value than the first portions 1334. In some embodiments, the second portion 1332 can be more compressible than the first portion 1334 at a given force. In some embodiments, the tube 1332 can be formed from silicone rubber, or other appropriately formed elastomeric materials. The tube portions 1334 are positioned between the connectors 1326, 1328 and the tubing connectors 1336. In some embodiments the first tube portions 1334 can be smaller diameter tubing than is used for the second tube portion 1332. The tubing connectors 1336 are configured to create a fluid tight seal between the second tube portion 1332 and the first tube portions 1334. In some embodiments, there are no first tube portions 1334 or tubing connectors 1336 and the second tube portion 1332 is coupled to the connector 1326 and the connector 1328.


A connector 1326 (e.g., a Spiros® closeable male connector or a first Chemolock™ connector manufactured by ICU Medical, Inc., of San Clemente, California) can be located at the end of the tubing assembly 1330 and can be used to connect to a corresponding connector 1338 (e.g., a Clave® connector or a second Chemolock™ connector manufactured by ICU Medical, Inc., of San Clemente, California) that is attached to the fluid source container 1320. Additional details relating to Clave® connectors and some variations are disclosed in the '866 Patent. In various embodiments disclosed herein, other types of connectors can also be used, such as a MicroCLAVE® connector (manufactured by ICU Medical, Inc., of San Clemente, California), or any other connector disclosed or described herein, including those in the '306 Patent, including, for example, clear connectors. When the connectors 1326 and 1338 are engaged, a fluid connection exists between the fluid source container 1320 and the connector 1326. A tube 1330 can extend from an outlet of the connector 1326 to a connector 1328 (e.g., a Spiros® closable male connector) which can be positioned at the opposite end of the tubing assembly 1330. A corresponding connector 1338 (e.g., a Clave® connector) can engage the connector 1328. The IV bag 1324 may have a supplemental line of tubing 1325 that can be configured to engage the connector 1338 to provide a fluid connection between the connector 1328 and the IV bag 1324.



FIGS. 7 through 9 illustrate an embodiment of a peristaltic pump 1350 used by the fluid transfer station 1318. The peristaltic pump has a cover (not shown), a mounting interface 1354, a plurality of lobes 1356, a rotor 1358, and a motor (not shown). The peristaltic pump is a positive displacement pump used for pumping fluid from the vial 1320 to the IV bag 1324. The fluid is transferred via a compressible tube 1332 fitted inside the mounting interface 1354. The rotor 1358 has a plurality of lobes 1356 attached to the external circumference of the rotor compresses the flexible tube. In some embodiments the lobes can be rollers, shoes, wipers, or other members that facilitate the operation of the pump. As the rotor 1358 turns, the part of tube under compression is compressed, or occludes, thus forcing the fluid to be pumped to move through the tube. As the tube 1332 opens to its natural state after the passing of the lobes 1356 fluid flow is induced.


In some embodiments, the motor may rotate the rotor 1358 in a single direction (e.g., only clockwise, or only counterclockwise). Thus, the fluid may be pumped through the tube in a single direction, from a first end that is always coupled to a source container (e.g., a vial, medical fluid bag, or other suitable container) to a second end that is always coupled to a target container (e.g., an IV bag, an elastomeric pump, a syringe, or other suitable container).


In some embodiments, the motor may be configured to rotate the rotor 1358 in both a clockwise and counterclockwise direction. Thus, a first end of the tube may be coupled to a source container when the rotor 1358 is rotating in one direction (e.g., clockwise) and coupled to a target container when the rotor 1358 is rotating in a different direction (e.g., counterclockwise). For example, the motor may rotate the rotor 1358 in a first direction to move fluid from a source container to a target container. When the transfer is substantially complete, the motor may reverse directions and rotate the rotor 1358 in the second direction for a short time to depressurize or decompress the tube such that the pressure is sufficiently low and fluid is not urged outside of the tube upon disconnection of the target container. As another example, the source container may serve initially as a target container, such as when the source container includes lyophilized medication. The container with lyophilized medication may be coupled to a first end of the tube, and a container with a diluent (e.g., saline or sterile water) may be coupled to a second end of the tube. The motor may initially rotate the rotor 1358 in the first direction to move diluent into the container with the lyophilized medication. After the lyophilized medication is sufficiently hydrated, the motor may be stopped, and a new target container may be coupled to the end of the tube to which the diluent container was coupled (or the diluent container may remain coupled to the tube to now serve as a target container). The motor may then begin rotating the rotor in the second direction to move hydrated medication into the new target container.


In some embodiments of the pump 1350, the cover (if present) is opened, the tube 1332 is positioned within the mounting interface 1354 (see FIG. 8), and the cover is closed. FIG. 9 illustrates the tubing 1332 mounted within the pump 1350 during operation. As shown the peristaltic pump lobes pinch the tube and compress the tubing, thereby moving fluid through the tube 1332.


The flow rate of the fluid through the pump 1350 can be controlled by the speed of the pump motor. The motor can be a variable speed motor and the fluid flow rate can be precisely controlled by varying the speed of the motor.


The peristaltic pump can operate at low pressures, and can avoid building up high pressures if the tubing is not connected to the IV bag. The pressures can be sufficiently low that the connector 1328 does not leak when it is closed and the pump is operating and connected to a fluid source, such as the vial 1320. In some embodiments, the system does not include sensors for detecting the presence of a target container.


Additionally, the system does not include sensors, in some embodiments, for detecting air bubbles because the system uses the weight of the target container to determine when the correct amount of fluid is transferred. The pump can continue to operate until the desired amount of fluid has been transferred to the target container.



FIG. 10 is an example of a flowchart for a method of using a fluid transfer system to transfer fluid from a source container to a target container 1360. The fluid transfer system can use the same or similar components as the fluid transfer systems 1200, 1250, and 1300 described herein. At block 1362, source container (e.g., a medical vial or other suitable container such as a bag, a bottle, or a vat, etc.) is coupled to a fluid transfer station. The source container contains fluid (e.g., chemotherapy drug or other medical fluid). The source container can have a compatible adapter device. The source container is in fluid communication with a tubing assembly. The tubing assembly is in fluid communication with a target container (e.g., an IV bag, an elastomeric pump, a syringe, or other suitable container). The tubing assembly can be a closed system that retains substantially entirely, or entirely, all of the fluid within the assembly, permitting the fluid transfer to occur in a substantially entirely, or entirely, closed system. A closed system can reduce or eliminate the risk of injury, waste, or damage caused by liquid or vapor leakage when connecting and disconnecting the components of the fluidics system. The source container can be mounted on a fluid transfer station. The fluid transfer station can include a housing that incorporates a peristaltic pump, controller, user interface, and communication interface. The tubing assembly has a portion of tubing mounted within a peristaltic pump.


At block 1364 a target container (such as an IV bag, an elastomeric pump, a syringe, or other appropriate target container) is coupled to the opposite end of the tubing assembly. In some embodiments, the target container may be positioned on a weight sensor. The weight sensor is configured to weigh the target container to determine the amount of fluid that is transferred into the target container. The weight sensor can be incorporated in a separate housing from the fluid transfer station. The weight sensor can have a communication interface and can be in communication with the controller. The weight sensor can provide information to the controller and receive instructions from the controller.


At block 1366, the fluid transfer station receives a command to transfer a specific amount of fluid from the source container to the target container. A user can provide commands through the user interface on the fluid transfer station. In some embodiments the commands can be received by a remote source. The user can identify a specific amount of fluid that is to be transferred (e.g., 10 ml, 30, ml, 100 ml, etc.) to the target container. After determining the amount of fluid to be transferred, the user can instruct the fluid transfer system to proceed with the transfer. In some embodiments the fluid transfer system can verify that the user has entered in the correct amount of fluid to be transferred.


At block 1368, the fluid transfer station processes the commands and prepares the system to transfer the fluid to the target container. The controller zeros the weight sensor to compensate for other masses in the system, such as the weight of the target container assembly. This allows the scale to determine the amount of fluid that will be transferred to the target container. After the scale has been zeroed the controller can initiate the transfer of fluid to the target container.


At block 1370, the controller instructs the motor of the peristaltic pump to operate pumping until the weight of the scale meets the specified weight of transferred fluid in the target container. The motor can vary the speed of the peristaltic pump based on the amount of fluid to transfer to the target container. As the amount of fluid approaches the specified amount, the speed of the motor can slow down, thereby reducing the flow rate of fluid into the target container, in order to increase accuracy. The controller can use an algorithm to determine the appropriate speeds at which to operate the pump. In some embodiments the controller can determine the flow rate associated with different speeds of the motor. The controller will continue to operate the motor until the specified amount has been transferred to the target container.


At block 1372 additional source containers can be coupled to the fluid transfer station. The source containers can continue to be replaced until the specified amount of fluid has been transferred to the target container. In some embodiments the motor can stop when the controller detects that the source is disconnected. In other embodiments the pump continues to operate until the specified weight is achieved regardless of whether the source container is disconnected. In some embodiments the controller can determine that fluid is not being transferred from the source container to the target container. In some embodiments the controller can receive input from a sensor to determine whether the source container is empty. In some embodiments the controller can determine that fluid is not being transferred from the source container because the motor is operating but fluid is not being transferred. In such instances, the controller can provide an audible alarm to the user, stop the operation of the motor, and/or perform other appropriate actions. A reservoir container can be used to transfer the contents of multiple source containers to the reservoir container prior to transferring the fluid to the target container.



FIG. 11 is an example embodiment of a fluid transfer system 1500, which can have features similar to, or the same as, the systems 1200, 1250, or 1300 described above or any other fluid transfer system described herein. The system 1500 can include a fluid transfer station 1502 and various auxiliary devices. For example, the system 1500 may include a destination sensor, such as a weight sensor 1504. As another example, the system 1500 may include a foot pedal (not shown). The fluid transfer station 1502 may communicate with the weight sensor 1504 and/or foot pedal via communication interfaces (not shown) in the respective devices. In some embodiments, the communication interfaces may be wired communication interfaces configured to be coupled to—and communicate via—a cable or other physical transmission medium between devices. In some embodiments, the communication interfaces may be wireless communication interfaces configured to transmit and receive wireless signals. In some embodiments, communication between components of the system 1500 and/or to external systems (other fluid transfer systems, a hospital information system, etc.) may be provided using any of the communication interfaces or features described above with respect to the fluid transfer system 1300.


As shown, the fluid transfer station 1502 may include a housing 1510, a peristaltic pump 1512 to effectuate the transfer of fluid from a source container to a target container, and a user interface 1514. The user interface 1514 can include a touchscreen, a keypad, a display, a microphone, a speaker, and/or other suitable interface devices for providing information to a user and/or for providing input from the user to a controller (not shown). Examples of user interface displays to manage various operations of the system 1500 are described in greater detail below. The user interface 1514 can be incorporated into the housing 1510. The fluid transfer station 1502 may also include various internal components as shown in FIG. 13 and described in greater detail below.


The weight sensor 1504 may have features similar to, or the same as, the weight sensor 1322. In some embodiments, the weight sensor 1504 can include a user interface (not shown) and a weighing surface 1540. The user interface can provide a visual indication of weight, and other information. In some embodiments the weight sensor 1504 can receive commands or instructions through the user interface from a user. In some embodiments the weight sensor 1504 does not include a user interface. The weighing surface 1540 is configured to provide a surface for a target container, such as an IV bag. The weighing surface 1540 can be sized so that an IV bag or other target container can be properly balanced and positioned on the weight sensor 1504 such that the weight sensor 1504 is configured to obtain an accurate measure of the weight of the IV bag or other target container. The weight sensor 1504 may provide information (e.g., weight measurements, current state of operation, etc.) to and receive commands from (e.g., zeroing the weight sensor) the fluid transfer station 1502 through a wired or wireless communication interface (not shown). As described in greater detail below, the weight sensor 1504 may be used to determine the amount of fluid transferred from the source container to the target container. These measurements can be used to calibrate the operation of the fluid transfer station 1502, to verify fluid transfer operations, and the like.


A foot pedal can be configured to provide user input to the system 1500 in addition to, or instead of, input provided through the user interface 1514. The foot pedal can allow the user to have both hands free (e.g., to replace IV bags after each fluid transfer of a multiple-IV bag order). In some embodiments, the foot pedal can issue a repeat command that causes the system 1500 to perform a fluid transfer of the same amount as the previous fluid transfer. In some embodiments, the foot pedal may provide an emergency stop command, such as when the foot pedal is activated during an active fluid transfer. The foot pedal can provide various other signals to the controller, such as an accept command, a pause command, a start command, a cancel command, etc.


In some embodiments, the system 1500 can include a printer that can be configured to automatically print labels for use with the fluid transfer station 1502 or other components. For example, when a fluid transfer is performed, the printer can print a label automatically to be placed on the target container (e.g., IV bag). The label can include information such as the fluid type, the concentration, the amount of fluid, the intended patient, the requesting doctor, etc. In some embodiments, the printer can be directly attached to the fluid transfer station 1502, such as by a wire or cable extending from a port on the fluid transfer station 1502. In some embodiments, the printer can communicate with the fluid transfer station 1502 by a wireless data connection. The controller of the fluid transfer station 1502 can be configured to generate the printer instructions for printing the labels. In some embodiments, some or all of the aspects of the printer may be incorporated into the fluid transfer station 1502 (e.g., located within a housing of the fluid transfer station 1502).


The fluid transfer station 1502 can be configured to transfer medical fluid from a source container (e.g., a vial, bag, or the like) to a target container (e.g., an IV bag) using the peristaltic pump 1512 and a fluidics assembly, such as the fluidics assembly 1530 shown in FIG. 12. The peristaltic pump 1512 is a positive displacement pump used for pumping fluid from a source container to a target container. The peristaltic pump 1512 may include a cover 1520 that shields components of the peristaltic pump 1512 and/or fluidics assembly 1530 during use, and prevents injury to users of the pump 1512. The peristaltic pump 1512 may also include a mounting interface 1522 configured to receive the fluidics assembly 1530. Fluid is transferred via a compressible tube 1532 of the fluidics assembly 1530 fitted inside the mounting interface 1522.


A rotor 1524 may be coupled to a motor of the peristaltic pump 1512, and the motor may cause the rotor 1524 to rotate around a central axis. One or more lobes 1526 may be attached to an external circumference of the rotor 1524 to compress the flexible tube 1532, which may be positioned substantially adjacent to the external circumference of the rotor 1524. In some embodiments the lobes 1526 can be rollers, shoes, wipers, or other members that facilitate the operation of the pump 1512. In some embodiments, the peristaltic pump 1512 may have the same number or a different number of lobes as the peristaltic pump 1350 described above. For example, while the peristaltic pump 1350 shown in FIG. 9 has four lobes 1356, the peristaltic pump 1512 shown in FIG. 12 has three lobes 1526. During operation, a plurality of lobes 1526 (e.g., at least two out of three lobes) may be in contact with the tube 1532 simultaneously, and the particular lobes 1526 that contact the tube 1532 vary over the course of operation as the rotor 1524 turns. As the rotor 1524 is turned by the motor of the peristaltic pump 1512, at least a portion of the tube 1532 is compressed, or occludes, thus forcing the fluid to move through the tangentially-oriented tube 1532 towards the target container. The tube 1532 may be resilient such that after the passing of the lobes 1526 over a portion of the tube 1532, the portion of the tube 1532 expands to its natural state and fluid flow is induced from the source container. This process of tube 1532 compression and expansion may be repeated for as long as the rotor 1524 rotates and the lobes 1526 contact and pass over the tube 1532. The volume of fluid transferred through the tube 1532 for each rotation (or fractional rotation) of the rotor 1524 may be determinable, as described in greater detail below, and may be used during operation of the peristaltic pump 1512 to accurately transfer a desired total volume of fluid to a target container.


The fluidics assembly 1530 may be similar to, or the same as, the fluidics assembly 1339 shown in FIGS. 5-6. In some embodiments, as shown in FIG. 12, the fluidics assembly 1530 may include a positioning member 1534 that is configured to fit within the mounting interface 1522 in a single or limited number of orientations, thereby ensuring proper installation for use of the fluidics assembly 1530. To install the fluidics assembly 1530, the cover 1520 is opened, the compressible tube 1532 and optional positioning member 1534 are positioned within the mounting interface 1522, and the cover 1520 is closed.


In some embodiments, as shown in FIGS. 11 and 12, the peristaltic pump 1512 is located on top of the housing 1510. In this configuration, the plane in which the rotor 1524 rotates is parallel (or substantially parallel) to the plane of the surface upon which the fluid transfer station 1502 is positioned, and is orthogonal (or substantially orthogonal) to the direction of gravity. Thus, gravity does not aid or impede the flow of fluid through the portion of the compressible tube 1532 that is installed into the mounting interface 1522, because the entire portion of the tube 1532 installed into the mounting interface 1522 is also positioned such that the path of fluid flow is substantially orthogonal to the direction of gravity at all points within the mounting interface 1522. Moreover, the source container and target container (not shown) may be positioned such that they are also coplanar with the rotor 1524, or are both above the plane of the rotor 1524, or are both below the plane of the rotor 1524. Therefore, any effect of gravity on one portion of the fluidics assembly 1530 are negated by the opposite effect of gravity on another portion of the fluidics assembly 1530. In contrast, if the plane in which the rotor 1524 rotates is parallel to (or is otherwise not orthogonal to) the direction of gravity, then gravity may aid or impede the flow of fluid at certain points within the compressible tube, which may cause inefficiencies and inconsistencies (e.g., due to backflow or free flow immediately before or after a lobe 1526 compresses and/or decompresses the tube).



FIG. 13 shows example internal components of the fluid transfer station 1502 to facilitate various features described herein. As shown, the fluid transfer station 1502 may include: one or more computer processors 1550, such as central processing units (“CPUs”); one or more communication interfaces 1552, such as a network interface cards (“NICs”), wireless communication antenna and related circuitry, etc.; one or more input/output device interfaces 1554; one or more motors 1556; one or more motor controller units (“MCUs”) 1558 to control the operation of the motor(s) 1556; and one or more computer readable memories 1560, such as random access memory (“RAM”) and/or other non-transitory computer-readable media. The computer readable memory 1560 may include data storage and/or computer program instructions that the computer processor(s) 1550 execute in order to implement one or more embodiments. For example, the computer readable memory 1560 can store an operating system 1562 that provides computer program instructions for use by the computer processor(s) 1550 in the general administration and operation of the fluid transfer station 1502. The computer readable memory 1560 may also include fluid transfer instructions 1564 for initiating and managing the transfer of fluid. The computer readable memory 1560 may also include an operational settings data store 1568 to store fluid transfer parameters and other operational settings of the fluid transfer station 1502. The computer readable memory 1560 may also include a drug library 1570—also referred to as a medication database—to store data regarding the medical fluids transferred via the fluid transfer station 1502.



FIG. 14 shows example user interface (“UI”) displays 400, 420, and 440 for setting up and managing a fluid transfer operation using the fluid transfer system 1500. During a particular transfer operation, the peristaltic pump 1512 moves the fluid from the source container through the fluidics assembly 1530 and into the target container. An example of operation of an embodiment of a peristaltic pump is described in greater detail above with reference to FIG. 10. A user may initiate such a fluid transfer operation by selecting a medication via UI display 400. The user may enter or search for a medication profile using a medication entry control 402. In some embodiments, commonly-used or recently-used medication profiles may be available for faster selection using a quick select control 404. Upon selection of a medication profile, information may be loaded from a drug library and displayed on the UI display 400. For example, medication profile information may be loaded from the drug library 1570 of the fluid transfer station 1502 or obtained from another data store via a network, such as from a HIS. The UI display 400 may be updated to show aspects of the medication profile, such as the name of the fluid, an identifier, a lot number, an expiration, and the like.


In addition to—or instead of—such descriptive properties of the medication profile, the fluid transfer station 1502 may present fluid properties of the medication profile. For example, fluid properties may include the specific gravity 406 of the fluid (also referred to as the relative density), and the source container volume 408. As described in greater detail below, such fluid properties may affect the operation of the fluid transfer station 1502 in performing a fluid transfer operation, including the calibration of the fluid transfer station 1502 and/or verification of the fluid transfer operation. In some embodiments, the UI controls used to display the specific gravity 406, source container volume 408, or other fluid properties of the medication profile may allow editing of the displayed data. For example, a user may be permitted to modify the specific gravity of the fluid that is the subject of the displayed medication profile. Once a property has been edited, the UI display 400 may indicate that the property has been edited, such as by displaying an icon, changing a font characteristic, and/or preventing additional edits. In some embodiments, editing of medication profile data may be restricted to only authorized users (e.g., only authorized users may be permitted to change the specific gravities associated with medication profiles).


Once a medication profile has been selected (and optionally edited), the user may move to the next step of fluid transfer setup by selecting or providing transfer parameters. In some embodiments, UI display 420 may provide editable controls for setting transfer parameters. As shown, volume control 422 may allow selection or entry of a volume of fluid to be transferred from a source container to a target container. A speed control 424 may allow selection or entry of a speed at which the volume of fluid is to be transferred. The speed—or flow rate—at which fluid moves through the fluidics assembly 1530 can be controlled by the speed at which the MCU 1558 operates the motor 1556, which in turn controls the speed at which the rotor 1524 rotates. Users may wish to control the fluid flow rate based on one or more factors such as the viscosity of the fluid being transferred, the volume of fluid being transferred, and the like. A direction control 426 may allow selection or entry of a direction at which the fluid is to be transferred. For example, the options may be “forward” in which fluid is transferred from the source container to the target container, and “reverse” in which fluid is transferred back to the source container from the target container, or back to the source container from the fluidics system, which fills with air to replace the fluid. The “reverse” direction may be desirable when the fluid is expensive and preserving all unused fluid for future operations is preferable rather than to disposing of fluid along with a disposable fluidics assembly.


In some embodiments, the user may select a fluid transfer mode. For example, UI display 420 may include selectable controls for initiating a single transfer 428 (e.g., filling a single target container to a specified volume) or a batch transfer 430 (e.g., repeatedly transferring the desired volume of fluid to a configurable number of target containers). Batch transfer mode is described in greater detail below with respect to FIGS. 17 and 18.


Once a single fluid transfer operation has been initiated, UI display 440 may present the status of the transfer operation. For example, UI display 440 may include a transferred volume portion 442 that dynamically updates to display the volume of fluid that has been transferred from the start of the operation to the present time. UI display 440 may include a specified volume portion 444 that displays the total volume originally selected (e.g., via UI display 420) to be transferred to the target container.


UI display 440 may also include a specified weight portion 446 that displays the total weight of the fluid to be transferred to the target container. The fluid transfer station 1502 may determine the value to be displayed in the specified weight portion 446 based on one or more fluid properties and/or other aspects of the fluid transfer configuration. For example, the fluid transfer station 1502 may multiply the specific gravity—e.g., obtained from the selected medication profile or inputted by the user or sensed by a sensor—by the specified volume to be transferred to the target container in order to determine the specified weight according to the following equation:






w
=

sg
×
v






where w=weight of the fluid in a given unit of weight (such as grams), sg=specific gravity of the fluid in the given unit of weight per a given unit of volume (such as grams per milliliter), and v=volume of the fluid in the given unit of volume (milliliters in this example).


The peristaltic pump 1512 may be configured to rotate the rotor 1524 a particular quantity of revolutions (or a particular fraction of a revolution) per volume unit of fluid to be transferred. For a transfer operation, the fluid transfer station 1502 may determine the quantity of revolutions that the rotor 1524 is to be rotated in order to cause transfer of the desired volume of fluid. The fluid transfer station 1502 may load an operation setting, such as a setting stored in the pump settings data store 1568, indicating the quantity of revolutions per unit of fluid to be transferred.


In some embodiments, multiple settings may be stored in the pump data store 1568, and individual settings may indicate a quantity of revolutions that the rotor 1524 is to be rotated per unit of fluid to be transferred, when the transfer operation is associated with different fluid properties and/or transfer parameters. For example, a first setting may be associated with fluid transfer operations occurring at a first speed (in terms of rotor revolutions per minute, units of fluid per minute, etc.), and a second setting may be associated with fluid transfer operations occurring at a second speed that is different than the first speed. As another example, a first setting may be associated with fluid transfer operations of fluids with a first specific gravity, while a second setting may be associated with fluid transfer operations of fluids with a second specific gravity that is different than the first specific gravity. As a further example, a first setting may be associated with fluid transfer operations of fluids with a first viscosity, while a second setting may be associated with fluid transfer operations of fluids with a second viscosity that is different than the first viscosity. In some embodiments, settings may be associated with combinations of fluid properties and/or fluid transfer parameters. For example, a first setting may be associated with fluid transfer operations of fluid with a first viscosity, where the transfer operations occur at a first speed, and so on.


The peristaltic pump 1512 may drift out of proper calibration for a number of reasons. For example, different fluidics assemblies may have subtle variances due to manufacturing tolerances that cause different volumes of fluid to be pumped through different assemblies for the same quantity of rotor rotations. As another example, as the motor is used its operational performance and specifications may gradually change due to wear. In some cases, environmental factors such as volume, humidity, altitude, barometric pressure, or the like may affect the calibration of the peristaltic pump 1512. To address these and other calibration issues, a calibration process may be performed on a periodic and/or on-demand basis.



FIG. 15 is a flowchart of an example process 500 that may be used to calibrate the fluid transfer station 1502 such that the volume of fluid transferred to a target container matches, or comes within a threshold amount or percentage of matching, the volume that was directed to be transferred. As described in greater detail below, the calibration process 500 involves transferring a desired volume of fluid using a current set of operational settings, measuring the volume that was actually transferred, determining an offset between the desired volume and the transferred volume, and adjusting the operational settings as needed so that future transfer operations result in the amount of volume transferred being the same as—or within an acceptable degree of accuracy of—the desired volume. Advantageously, in some embodiments the calibration process 500 can use the weight sensor 1504 and fluid properties in medication profiles to determine whether to modify operational settings—and if so, the degree to which the operational settings are to be modified—without requiring any specialized target container for the transferred fluid, and without requiring the transferred fluid to be removed from the target container for a volume measurement. Rather, the measurements during the calibration process 500 may be taken after transferring fluid to the same standard target containers used in routine transfer operations, including target containers from which the fluid will eventually be administered to patients. In this way, calibration may be performed more easily, and more often if needed, than alternative calibration methods.


The process 500 begins at block 502. The process may begin in response to an event, such as when the fluid transfer station 1502 is powered on, at recommended intervals, or on-demand. In some embodiments, calibration may be recommended or required periodically or in response to an event. For example, calibration may be recommended or required after each change of fluidics assembly, each change of desired volume, each change of target container type, or when the fluid transfer station 1502 has transferred a threshold volume of fluid since the last calibration (e.g., every 10,000, 30,000, or 100,000 milliliters of fluid transferred).


When the process 500 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device. For example, FIG. 13 shows an example fluid transfer station 1502 in which calibration instructions 1566 may be loaded into memory 1560, and executed by a processor 1550.


At decision block 504, the fluid transfer station 1502 can determine whether a fluidics assembly has been installed and primed. For example, the fluid transfer station 1502 may prompt a user via user interface 1514 to indicate whether the fluidics assembly is primed. If the fluidics assembly has not been primed, the process 500 may proceed to block 506 to prime the assembly. Otherwise, if the assembly has been primed, the process 500 may proceed to block 508.


At block 508, the fluid transfer station 1502 can obtain fluid properties for the fluid that is to be used during the calibration operation. In some embodiments, a user interface display with features that are similar to—or the same as—UI display 400 may be used to select the fluid that is to be used during the calibration operation. For example, determining fluid properties can include determining the specific gravity of the fluid to be transferred. The fluid transfer station 1502 may load the specific gravity from the drug library 1570 after selection of the particular fluid to be transferred. In some embodiments, other fluid properties may be determined, such as the viscosity of the fluid to be transferred.


At block 510, the fluid transfer station 1502 can obtain transfer parameters for the calibration operation. In some embodiments, a user interface display with features that are similar to—or the same as—UI display 420 may be used to select the volume of fluid that is to be transferred during the calibration operation. In some embodiments, other fluid transfer parameters properties may be determined, such as the speed at which fluid is to be transferred. The fluid transfer station 1502 may also obtain the current operational settings in order to manage the transfer of fluid. For example, the fluid transfer station 1502 may load a setting, stored in the pump settings data store 1568, indicating the quantity of revolutions per unit of fluid to be transferred. The operational setting may be a universal setting that applies to all fluids and transfer operations, or it may be an operational setting that applies to transfer of fluids with specific fluid properties (e.g., viscosity, specific gravity, etc.) and/or using specific transfer parameters (e.g., speed, type of fluidics assembly, etc.).


At block 512, the weight sensor 1504 can be initialized. Initialization of the weight sensor 1504 may be performed to ensure that weight measurements generated by the weight sensor 1504 are accurate. In some embodiments, the weight sensor may be initialized to account for tare. For example, the weight sensor 1504 may be initialized such that it produces a weight measure of 0.0 units when an empty target container is on the weight sensor 1504. Accordingly, when fluid is transferred into the target container, the weight sensor 1504 will indicate the weight of the fluid only, and not the target container.


At block 514, the fluid transfer station 1502 can initiate transfer of the indicated volume of fluid to the target container. Transfer of the volume of fluid may proceed in a manner similar to—or the same as—transfer of fluid in a non-calibration-related transfer operation as described in greater detail above. In some embodiments, a user interface display with features that are similar to—or the same as—UI display 440 may be used to present the status of the fluid transfer operation.


At block 516, a measurement of the transferred volume of fluid can be determined. The measurement may be a weight measurement of the transferred fluid, as measured by the weight sensor 1504. The measurement may be provided from the weight sensor 1504 to the fluid transfer station 1502 via wired or wireless transmission. For example, after the fluid transfer station 1502 completes transfer of the volume of fluid using the operational settings, the fluid transfer station 1502 may request, read, receive, or otherwise obtain a measurement from the weight sensor 1504. In some embodiments, rather than obtaining the weight via transmission from the weight sensor 1504, the weight may be provided to the fluid transfer station 1502 by a user via a user interface. For example, UI display 600 shown in FIG. 6 may provide an interactive control 602 for entering, selecting, or otherwise providing a weight measurement. The user may review a user interface of the weight sensor 1504 to determine the weight measured by the weight sensor 1504, and then provide the determined weight measurement to the fluid transfer station 1502 via the UI display 600.


At block 518, the fluid transfer station 1502 can determine an observed volume of fluid transferred to the target container based on the weight measurement obtained in block 516 above, and a property of the fluid such as the specific gravity of the fluid. For example, the fluid transfer station 1502 may divide the measured weight of the transferred fluid by the specific gravity from the selected medication profile to arrive at the observed volume transferred to the target container, according to the following equation:






v
=

w
/
sg






where w=weight of the fluid in a given unit of weight (such as grams), sg=specific gravity of the fluid in the given unit of weight per a given unit of volume (such as grams per milliliter), and v=volume of the fluid in the given unit of volume (such as milliliters).


At block 520, the fluid transfer station 1502 can determine an adjustment to address any difference between the observed volume and the desired volume. The fluid transfer station 1502 may first analyze the observed volume with respect to the desired volume to determine whether there is a difference or “offset.” If there is an offset, the fluid transfer station 1502 may adjust an operational setting to address the offset. For example, the fluid transfer station 1502 may determine that the number of rotor revolutions previously used to transfer the desired volume is now associated with the observed volume, which is different than the desired volume. A modification to the operational setting that represents the number of rotor revolutions may be made to ensure that use of the operational setting produces the desired volume. In some embodiments, adjusting the setting may be based on the magnitude and direction of the offset. For example, the offset may be based on the percentage of the observed volume in terms of the desired volume: a positive value indicates greater than 100% of the desired volume has been transferred, and a negative value indicates less than 100% of the desired volume has been transferred. The operational setting may be adjusted by the offset value: reducing the setting by a percentage corresponding to the offset value if the sign of the offset is positive (indicating an overfill), and increasing the setting by a percentage corresponding to the offset value if the sign of the offset is negative (indicating an underfill).


At decision block 522, the fluid transfer station 1502 can determine whether the offset determined above at block 520 is within a calibration threshold. An offset exceeding a calibration threshold may indicate that a relatively large change to the operational setting was made. A large offset may have been anomalous, or a large change to the operational setting may be associated with less than desired precision. In such cases, the calibration process 500 may return to block 504 and be performed again to verify that the change made to the operational setting indeed results in the desired volume of fluid being transferred. The re-performance of the calibration process may be automatic or required. For example, in response to determining that the offset is outside of the calibration threshold, use of the fluid transfer station 1502 may not be permitted until the calibration process 500 is performed again. In some embodiments, re-performance of the calibration process 500 may be optional or manually initiated. For example, a user interface such as UI display 620 shown in FIG. 6 may provide a warning or other indication 622 that the offset exceeds a calibration threshold. A user may accept the calibration change (e.g., by activating an acceptance control 624), or choose to perform another calibration process (e.g., by activating a re-calibration control 626) to verify that the change has brought the fluid transfer station 1502 within the desired level of calibration.


At block 524, the process 500 may terminate.


In addition to being performed on-demand or in response to particular recommendations, calibration may be incorporated into a batch process at regular intervals. In some embodiments, a user may configure the fluid transfer station 1502 to transfer a same volume of fluid to a predetermined number of target containers without requiring reconfiguration of the fluid transfer station 1502 between target containers. For example, a same volume of saline (e.g., 100 ml) may be transferred from a large source container to multiple individual target containers (e.g., 5, 10, 50, or more individual target containers) after a single setup operation, without requiring a corresponding number of setup operations (e.g., without requiring 5, 10, 50, or more setup operations using the UI displays 400, 420, 440). In order to detect and address any calibration issues that may arise during the batch operation, periodic calibration checks may be performed during the batch process.



FIG. 17 is a flowchart of an example process 700 that may be used to perform a batch transfer of fluid to multiple target containers while periodically checking the calibration of the fluid transfer station 1502. As described in greater detail below, the batch transfer process 700 involves iteratively transferring a desired volume of fluid using a current set of operational settings, periodically measuring the volume that was actually transferred, and adjusting the operational settings as needed. Advantageously, the batch transfer process 700 uses the weight sensor 1504 and fluid properties in medication profiles to verify the calibration of the fluid transfer station 1502.


The process 700 begins at block 702. The process may begin in response to an event, such as when a user accesses a user interface to initiate a batch transfer process. When the process 700 is initiated, a set of executable program instructions stored on one or more non-transitory computer-readable media (e.g., hard drive, flash memory, removable media, etc.) may be loaded into memory (e.g., random access memory or “RAM”) of a computing device. For example, FIG. 13 shows an example fluid transfer station 1502 in which fluid transfer instructions 1564 may be loaded into memory 1560, and executed by a processor 1550.


At block decision block 704, the fluid transfer station 1502 can determine whether a fluidics assembly has been installed and primed. For example, the fluid transfer station 1502 may prompt a user via user interface 1514 to indicate whether the fluidics assembly is primed. If the fluidics assembly has not been primed, the process 700 may proceed to block 706 to prime the assembly. Otherwise, if the assembly has been primed, the process 700 may proceed to block 708.


At block 708, the fluid transfer station 1502 can obtain fluid properties for the fluid that is to be used during the batch transfer operation. In some embodiments, a user interface display with features that are similar to—or the same as—UI display 400 may be used to select the fluid that is to be used during the batch transfer operation. For example, determining fluid properties can include determining the specific gravity of the fluid to be transferred. The fluid transfer station 1502 may load the specific gravity from the drug library 1570 after selection of the particular fluid to be transferred. In some embodiments, other fluid properties may be determined, such as the viscosity of the fluid to be transferred.


At block 710, the fluid transfer station 1502 can obtain transfer parameters for the batch transfer operation. In some embodiments, a user interface display with features that are similar to—or the same as—UI display 420 may be used to select the volume to be transferred in each segment of the batch transfer operation, and the speed at which the desired volume is to be transferred in each segment. In addition to these transfer parameters, additional parameters may be set for the batch transfer operation. A user interface display, such as UI display 800 in FIG. 18, may be presented to facilitate the configuration of additional parameters of batch transfer operation. For example, the UI display 800 may include an interactive segment entry control 802 for selecting or entering a desired quantity of target containers into which the desired volume of fluid is to be transferred. The batch transfer operation will include a segment for each target container. The UI display 800 may also include an interactive interval time control 804 for selecting or entering the desired length of time to be used as the interval between each segment of the batch transfer operation. The interval provides time for the user of the fluid transfer station 1502 to perform various tasks related to completion of a segment and/or preparation for a next segment, such as disconnecting a target container—filled during the most-recently-completed segment of the batch transfer operation—from the fluidics system, connecting a new empty target container to the fluidics system for the next segment of the batch transfer operation, etc.


At block 712, a segment of the batch transfer process may be performed. The fluid transfer performed in each individual segment of the batch transfer process may proceed in a manner similar to—or the same as—transfer of fluid in a non-batch transfer operation as described in greater detail above. In some embodiments, a user interface display such as UI display 820 may be used to present the status and results of the current segment. UI display 820 may include a segment indicator portion 822 to indicate which segment of the batch transfer operation is currently in progress, a transferred volume portion 824 to indicate the volume transferred the far during the current segment of the batch transfer process, a desired volume portion 826 to indicate the desired volume to be transferred during the current segment, and an interval indicator portion 828 to indicate the length of the interval between segments (e.g. a quantity of units of time, such as seconds).


At decision block 714, after the current segment of the batch transfer process has completed, the fluid transfer station 1502 can determine whether a number of segments transferred since the last calibration check—or since the beginning of the process 700—has reached a verification threshold. If so, the process proceeds to block 716 to verify the calibration based on the most recently completed segment of the batch transfer process. Otherwise, the process may continue at decision block 718. The verification threshold may be a predetermined value, such as an operational setting of the fluid transfer station 1502. For example, the threshold may be set to a value (e.g., 10, 50, 100) when the fluid transfer station 1502 is manufactured, maintained by an administrator, or the like. In some embodiments, the verification threshold may be configurable for a given batch transfer process. For example, a UI display such as UI display 800 may include an interactive control for selecting or entering the verification threshold to be used for the current batch transfer process,


At block 716, the calibration of the fluid transfer station 1502 can be verified based on the most recently completed segment of the fluid transfer process. The calibration may be verified based on the weight of the filled target container. In some embodiments, a process that is the same—or similar to—the calibration process 500 described in greater detail above may be used. For example, a user may place the filled target container on the weight sensor 1504. The weight measured by the weight sensor 1504 may be provided to the fluid transfer station 1502 automatically (e.g., via wired or wireless communication between the weight sensor 1504 and the fluid transfer station 1502), or manually (e.g., the user may enter the weight measurement in a user interface of the fluid transfer station 1502). The fluid transfer station 1502 may determine the observed volume of fluid transferred to the target container based on the weight using a fluid property, such as the specific gravity of the fluid, as described in greater detail above. The fluid transfer station may further determine an offset between the observed volume of fluid and the desired volume fluid, as also described in greater detail above. An operational setting may be automatically changed based on the offset, or the user may be prompted as to whether to update the operational setting.


At decision block 718, the fluid transfer station 1502 can determine whether there are any additional segments of the batch transfer process to be completed. If so, the process 700 can proceed to block 720. Otherwise, the process may terminate at block 722.


At block 720, there are one or more additional segments of the batch transfer process to be completed, and the fluid transfer station 1502 can wait for the designated interval between segments before returning to block 712 for the next segment. The interval provides time for the user of the fluid transfer station 1502 to perform various tasks related to completion of a segment and/or preparation for a next segment, such as disconnecting a target container—filled during the most-recently-completed segment of the batch transfer operation—from the fluidics system, connecting a new empty target container to the fluidics system for the next segment of the batch transfer operation, etc. In some embodiments, a UI display (such as UI display 820) may include a dynamic interval time indicator (not shown) that indicates the amount of time remaining in the interval before the next segment of the batch transfer process is to begin. If the user requires additional time between segments or otherwise wishes to pause or stop the batch transfer process, the user may activate a control on a UI display, activate the pedal, or use other input method.


Depending on the embodiment, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (e.g., not all described operations or events are necessary for the practice of the algorithm). Moreover, in certain embodiments, operations or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially.


The various illustrative logical blocks, modules, routines, and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, or combinations of electronic hardware and computer software. To clearly illustrate this interchangeability, various illustrative components, blocks, modules, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware, or as software that runs on hardware, depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.


Moreover, the various illustrative logical blocks and modules described in connection with the embodiments disclosed herein can be implemented or performed by a machine, such as programmable computer central processing unit (CPU), a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A processor device can be a microprocessor, but in the alternative, the processor device can be a controller, microcontroller, or state machine, combinations of the same, or the like. A processor device can include electrical circuitry configured to process computer-executable instructions. In another embodiment, a processor device includes an FPGA or other programmable device that performs logic operations without processing computer-executable instructions. A processor device can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. Although described herein primarily with respect to digital technology, a processor device may also include primarily analog components. For example, some or all of the algorithms described herein may be implemented in analog circuitry or mixed analog and digital circuitry. A computing environment can include any type of computer system, including, but not limited to, a computer system based on a microprocessor, a mainframe computer, a digital signal processor, a portable computing device, a device controller, or a computational engine within an appliance, to name a few.


The elements of a method, process, routine, or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor device, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of a non-transitory computer-readable storage medium. An exemplary storage medium can be coupled to the processor device such that the processor device can read information from, and write information to, the storage medium. When a method, process, routine, or algorithm is to be executed, executable instructions may be loaded to or accessed at a storage medium and executed by one or more processors. In some embodiments, the storage medium can be integral to the processor device. The processor device and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal.


Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without other input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list.


Disjunctive language such as the phrase “at least one of X, Y, Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to present that an item, term, etc., may be either X, Y, or Z, or any combination thereof (e.g., X, Y, and/or Z). Thus, such disjunctive language is not generally intended to, and should not, imply that certain embodiments require at least one of X, at least one of Y, or at least one of Z to each be present.


Unless otherwise explicitly stated, articles such as “a” or “an” should generally be interpreted to include one or more described items. Accordingly, phrases such as “a device configured to” are intended to include one or more recited devices. Such one or more recited devices can also be collectively configured to carry out the stated recitations. For example, “a processor configured to carry out recitations A, B and C” can include a first processor configured to carry out recitation A working in conjunction with a second processor configured to carry out recitations B and C.


While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it can be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As can be recognized, certain embodiments described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. The scope of certain embodiments disclosed herein is indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A medical fluid transfer system comprising: a pump comprising a rotor with one or more lobes, wherein the pump is configured to transfer fluid through a tube assembly having a first connector configured to couple to a source container and a second connector configured to couple to a target container;a destination sensor configured to output information about the target container; anda control system configured to: receive an instruction to transfer a desired volume of a medical fluid to the target container;operate the pump based on the instruction and an operational setting associated with a first quantity of rotations that the rotor is to be rotated for transfer of a fluid volume of the medical fluid;receive measurement data representing a measurement of the target container by the destination sensor;determine a difference between a transferred volume of the medical fluid and the desired volume of the medical fluid based at least partly on the measurement data and a fluid property of the medical fluid;adjust the operational setting based on the difference to a second quantity of rotations that the rotor is to be rotated for transfer of the fluid volume of the medical fluid; andoperate the pump based on the operational setting that has been adjusted.
  • 2. The medical fluid transfer system of claim 1, further comprising the tube assembly.
  • 3. The medical fluid transfer system of claim 1, wherein the destination sensor comprises a weight sensor, and wherein the measurement data represents a weight of the target container after operation of the pump.
  • 4. The medical fluid transfer system of claim 1, wherein the control system comprises a user interface, and wherein the measurement data is received by the control system via the user interface.
  • 5. The medical fluid transfer system of claim 1, wherein the control system comprises a first communication interface, wherein the destination sensor comprises a second communication interface, wherein the destination sensor transmits the measurement data via the second communication interface, and wherein the measurement data is received by the control system via the first communication interface.
  • 6. The medical fluid transfer system of claim 1, wherein the fluid property comprises a specific gravity of the medical fluid, and wherein the control system is further configured to determine the transferred volume of medical fluid based on the specific gravity and a weight of the target container represented by the measurement data.
  • 7. The medical fluid transfer system of claim 1, wherein the control system is further configured to determine an adjustment to the operational setting based on a magnitude of the difference.
  • 8. The medical fluid transfer system of claim 1, wherein the pump is a peristaltic pump.
  • 9. The medical fluid transfer system of claim 8, further comprising a housing, wherein the housing is configured to support the peristaltic pump in a position in which a plane of rotation of the rotor is substantially orthogonal to a direction of gravity during operation of the peristaltic pump.
  • 10. The medical fluid transfer system of claim 8, wherein the peristaltic pump is configured to operate at a plurality of speed settings.
  • 11. The medical fluid transfer system of claim 1, wherein the control system is further configured to manage a batch transfer operation in which the control system operates the pump to transfer the desired volume of the medical fluid to each of a plurality of target containers.
  • 12. The medical fluid transfer system of claim 11, wherein the control system is further configured to delay a subsequent segment of the batch transfer operation for a predetermined time interval after completion of a prior segment of the batch transfer operation.
  • 13. The medical fluid transfer system of claim 11, wherein the control system is further configured to determine that the medical fluid has been transferred to a threshold quantity of target containers during the batch transfer operation, wherein the measurement data is received in response to the control system determining that the medical fluid has been transferred to the threshold quantity of target containers.
  • 14. A method for calibrating a medical fluid transfer system, the method comprising: under control of a control system of the medical fluid transfer system, the control system comprising one or more computer processors configured to execute specific instructions: receiving an instruction to transfer a desired volume of a medical fluid to a target container;operating a pump of the medical fluid transfer system based on the instruction and an operational setting, wherein the pump comprises a rotor and one or more lobes, and wherein the operational setting is associated with a first quantity of rotations that the rotor is to be rotated for transfer of a fluid volume of the medical fluid;receiving measurement data representing a measurement of the target container by a destination sensor;determining a difference between a transferred volume of the medical fluid and the desired volume of the medical fluid based at least partly on the measurement data and a fluid property of the medical fluid; andadjusting the operational setting based on the difference to a second quantity of rotations that the rotor is to be rotated for transfer of the fluid volume of the medical fluid.
  • 15. The method of claim 14, further comprising operating the pump using the operational setting that has been adjusted.
  • 16. The method of claim 14, further comprising determining the transferred volume of the medical fluid based on the fluid property and the measurement data, wherein the fluid property comprises a specific gravity of the medical fluid, and wherein the measurement data represents a weight of the target container.
  • 17. The method of claim 14, further comprising determining an adjustment to the operational setting based on a magnitude of the difference.
  • 18. The method of claim 14, further comprising loading the operational setting from a data store, wherein the operational setting indicates a quantity of rotations that a rotor of the pump is to be rotated for transfer of one or more volumetric units of the medical fluid.
  • 19. The method of claim 14, further comprising: managing a batch transfer operation in which the desired volume of the medical fluid is transferred to each of a plurality of target containers; anddelaying a segment of the batch transfer operation for a predetermined time interval after completion of a prior segment of the batch transfer operation.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation application of PCT Application No. PCT/US2021/041891 (the “'891 application”), filed Jul. 15, 2021, and titled FLUID TRANSFER DEVICES AND METHODS OF USE, which claims priority to U.S. Provisional Patent Application No. 63/054,568 (the “'568 application”), filed Jul. 21, 2020, and titled FLUID TRANSFER DEVICES AND METHODS OF USE, the contents of each of which are hereby incorporated by reference in their entireties and made part of this specification for all that they disclose.

US Referenced Citations (1571)
Number Name Date Kind
3768084 Haynes Oct 1973 A
3770354 Tsuruta et al. Nov 1973 A
3778702 Finger Dec 1973 A
3806821 Niemeyer et al. Apr 1974 A
3838565 Carlyle Oct 1974 A
3854038 Mckinley Dec 1974 A
3886459 Hufford et al. May 1975 A
3890554 Yoshitake et al. Jun 1975 A
3894431 Muston et al. Jul 1975 A
3898637 Wolstenholme Aug 1975 A
3901231 Olson Aug 1975 A
3909693 Yoshitake et al. Sep 1975 A
3910701 Henderson Oct 1975 A
3911343 Oster Oct 1975 A
3919608 Usami et al. Nov 1975 A
3921622 Cole Nov 1975 A
3930404 Ryden, Jr. Jan 1976 A
3933431 Trujillo et al. Jan 1976 A
3935876 Massie et al. Feb 1976 A
3944963 Hively Mar 1976 A
3966358 Heimes et al. Jun 1976 A
3971980 Jungfer et al. Jul 1976 A
3974681 Namery Aug 1976 A
3974683 Martin Aug 1976 A
3985467 Lefferson Oct 1976 A
3990444 Vial Nov 1976 A
3997888 Kremer Dec 1976 A
4005724 Courtot Feb 1977 A
4014206 Taylor Mar 1977 A
4038982 Burke Aug 1977 A
4039269 Pickering Aug 1977 A
4048474 Olesen Sep 1977 A
4049954 Da Costa Vieira et al. Sep 1977 A
4055175 Clemens et al. Oct 1977 A
4068521 Cosentino et al. Jan 1978 A
4078562 Friedman Mar 1978 A
4089227 Falgari et al. May 1978 A
4094318 Burke Jun 1978 A
4105028 Sadlier et al. Aug 1978 A
4114144 Hyman Sep 1978 A
4151845 Clemens May 1979 A
4155362 Jess May 1979 A
4173224 Marx Nov 1979 A
4181610 Shintani et al. Jan 1980 A
4183244 Kohno et al. Jan 1980 A
4195515 Smoll Apr 1980 A
4210138 Jess et al. Jul 1980 A
4213454 Shim Jul 1980 A
4217993 Jess et al. Aug 1980 A
4240294 Grande Dec 1980 A
4240438 Updike et al. Dec 1980 A
4244365 McGill Jan 1981 A
4256437 Brown Mar 1981 A
4261356 Turner et al. Apr 1981 A
4264861 Radu et al. Apr 1981 A
4265240 Jenkins May 1981 A
4270532 Franetzki et al. Jun 1981 A
4277226 Archibald et al. Jul 1981 A
4278085 Shim Jul 1981 A
4280495 Lampert Jul 1981 A
4282872 Franetzki et al. Aug 1981 A
4286202 Clancy et al. Aug 1981 A
4290346 Bujan Sep 1981 A
4291692 Bowman et al. Sep 1981 A
4292405 Mascoli Sep 1981 A
4298357 Permic Nov 1981 A
4308866 Jeliffe Jan 1982 A
4312341 Zissimopoulos Jan 1982 A
4319568 Tregoning Mar 1982 A
4322201 Archibald Mar 1982 A
4323849 Smith Apr 1982 A
4324662 Schnell Apr 1982 A
4328800 Marx May 1982 A
4328801 Marx May 1982 A
4333045 Oltendorf Jun 1982 A
4343316 Jespersen Aug 1982 A
4344429 Gupton et al. Aug 1982 A
4346707 Whitney et al. Aug 1982 A
4360019 Portner et al. Nov 1982 A
4366384 Jensen Dec 1982 A
4367736 Gupton Jan 1983 A
4370983 Lichtenstein et al. Feb 1983 A
4373527 Fischell Feb 1983 A
4379452 DeVries Apr 1983 A
4381005 Bujan Apr 1983 A
4384578 Winkler May 1983 A
4385247 Satomi May 1983 A
4391598 Thompson Jul 1983 A
4392849 Petre et al. Jul 1983 A
4394862 Shim Jul 1983 A
4395259 Prestele et al. Jul 1983 A
4397194 Soltz Aug 1983 A
4399362 Cormier et al. Aug 1983 A
4407659 Adam Oct 1983 A
4411651 Schulman Oct 1983 A
4418565 St. John Dec 1983 A
4432699 Beckman et al. Feb 1984 A
4432761 Dawe Feb 1984 A
4432762 Dawe Feb 1984 A
4443218 Decant, Jr. et al. Apr 1984 A
4444546 Pazemenas Apr 1984 A
4447191 Bilstad et al. May 1984 A
4447224 Decant, Jr. et al. May 1984 A
4453931 Pastrone Jun 1984 A
4457751 Rodler Jul 1984 A
4463301 Moriguchi et al. Jul 1984 A
4464170 Clemens Aug 1984 A
4467654 Murakami et al. Aug 1984 A
4468222 Lundquist Aug 1984 A
4468601 Chamran et al. Aug 1984 A
4469481 Kobayashi Sep 1984 A
4475666 Bilbrey et al. Oct 1984 A
4475901 Kraegen et al. Oct 1984 A
4477756 Moriguchi Oct 1984 A
4479760 Bilstad et al. Oct 1984 A
4480218 Hair Oct 1984 A
4480483 McShane Nov 1984 A
4483202 Ogua et al. Nov 1984 A
4487601 Lindemann Dec 1984 A
4492909 Hartwig Jan 1985 A
4496346 Mosteller Jan 1985 A
4498843 Schneider et al. Feb 1985 A
4501531 Bilstad et al. Feb 1985 A
4504263 Steuer Mar 1985 A
4507112 Hillel Mar 1985 A
4510266 Eertink Apr 1985 A
4515584 Abe et al. May 1985 A
4519792 Dawe May 1985 A
4521212 Ruschke Jun 1985 A
4525163 Slavik et al. Jun 1985 A
4526568 Clemens et al. Jul 1985 A
4526574 Pekkarinen Jul 1985 A
4529401 Leslie et al. Jul 1985 A
4533350 Danby et al. Aug 1985 A
4543955 Schroeppel Oct 1985 A
4551134 Slavik et al. Nov 1985 A
4553958 LeCocq Nov 1985 A
4559036 Wunsch Dec 1985 A
4559037 Franetzki et al. Dec 1985 A
4559044 Robinson Dec 1985 A
4559454 Kramer Dec 1985 A
4565500 Jeensalute et al. Jan 1986 A
4583981 Urquhart et al. Apr 1986 A
4587473 Turvey May 1986 A
4607520 Dam Aug 1986 A
4617014 Cannon et al. Oct 1986 A
4624661 Arimond Nov 1986 A
4627835 Fenton, Jr. Dec 1986 A
4633878 Bombardieri Jan 1987 A
4634426 Kamen Jan 1987 A
4634427 Hannula et al. Jan 1987 A
4636144 Abe et al. Jan 1987 A
4637813 DeVries Jan 1987 A
4645489 Krumme Feb 1987 A
4648869 Bobo, Jr. Mar 1987 A
4652260 Fenton, Jr. et al. Mar 1987 A
4658244 Meijer Apr 1987 A
4668216 Martin May 1987 A
4668945 Aldrovandi et al. May 1987 A
4673334 Allington et al. Jun 1987 A
4673389 Archibald et al. Jun 1987 A
4676776 Howson et al. Jun 1987 A
4677359 Enami et al. Jun 1987 A
4678979 Hori Jul 1987 A
4678998 Muramatsu Jul 1987 A
4679562 Luksha Jul 1987 A
4683428 Gete Jul 1987 A
4685903 Cable et al. Aug 1987 A
4690673 Blomquist Sep 1987 A
4691153 Nishimura Sep 1987 A
4692145 Weyant Sep 1987 A
4696671 Epstein et al. Sep 1987 A
4697129 Enami et al. Sep 1987 A
4702675 Aldrovandi et al. Oct 1987 A
4705506 Archibald et al. Nov 1987 A
4710106 Iwata et al. Dec 1987 A
4714462 DiDomenico Dec 1987 A
4714463 Archibald et al. Dec 1987 A
4718576 Tamura et al. Jan 1988 A
4720636 Benner Jan 1988 A
4722224 Scheller et al. Feb 1988 A
4722734 Kolin Feb 1988 A
4731051 Fischell Mar 1988 A
4731057 Tanaka et al. Mar 1988 A
4737711 O'Hare Apr 1988 A
4739346 Buckley Apr 1988 A
4741732 Crankshaw et al. May 1988 A
4741736 Brown May 1988 A
4748857 Nakagawa Jun 1988 A
4751445 Sakai Jun 1988 A
4756706 Kerns et al. Jul 1988 A
4758228 Williams Jul 1988 A
4763525 Cobb Aug 1988 A
4764166 Spani et al. Aug 1988 A
4764697 Christiaens Aug 1988 A
4769001 Prince Sep 1988 A
4776842 Franetzki et al. Oct 1988 A
4781687 Wall Nov 1988 A
4784576 Bloom et al. Nov 1988 A
4785184 Bien et al. Nov 1988 A
4785799 Schoon et al. Nov 1988 A
4785969 McLaughlin Nov 1988 A
4786800 Kamen Nov 1988 A
4789014 DiGianfilippo Dec 1988 A
4797655 Orndal et al. Jan 1989 A
4803389 Ogawa et al. Feb 1989 A
4803625 Fu et al. Feb 1989 A
4818186 Pastrone et al. Apr 1989 A
4820281 Lawler Apr 1989 A
4821558 Pastrone et al. Apr 1989 A
4828545 Epstein et al. May 1989 A
4828693 Lindsay May 1989 A
4829448 Balding et al. May 1989 A
4838856 Mulreany et al. Jun 1989 A
4838857 Strowe et al. Jun 1989 A
4840542 Abbott Jun 1989 A
4842584 Pastrone et al. Jun 1989 A
4845487 Frantz et al. Jul 1989 A
4846792 Bobo et al. Jul 1989 A
4850805 Madsen et al. Jul 1989 A
4851755 Fincher Jul 1989 A
4854324 Hirschman et al. Aug 1989 A
4856339 Williams Aug 1989 A
4857048 Simons et al. Aug 1989 A
4857050 Lentz et al. Aug 1989 A
4858154 Anderson et al. Aug 1989 A
4863425 Slate et al. Sep 1989 A
4865584 Epstein et al. Sep 1989 A
4869722 Heyman Sep 1989 A
4874359 White et al. Oct 1989 A
4881413 Georgi et al. Nov 1989 A
4882575 Kawahara Nov 1989 A
4884013 Jackson et al. Nov 1989 A
4884065 Crouse et al. Nov 1989 A
4886422 Takeuchi et al. Dec 1989 A
4898576 Philip Feb 1990 A
4898578 Rubalcaba, Jr. Feb 1990 A
4906103 Kao Mar 1990 A
4908017 Howson et al. Mar 1990 A
4908019 Urquhart et al. Mar 1990 A
4910475 Lin Mar 1990 A
4919595 Likuski et al. Apr 1990 A
4919596 Slate et al. Apr 1990 A
4925444 Orkin et al. May 1990 A
4927411 Pastrone et al. May 1990 A
4930358 Motegi et al. Jun 1990 A
4936820 Dennehey Jun 1990 A
4936828 Chiang Jun 1990 A
4938079 Goldberg Jul 1990 A
4943279 Samiotes et al. Jul 1990 A
4946439 Eggers Aug 1990 A
4947856 Beard Aug 1990 A
4950235 Slate et al. Aug 1990 A
4950244 Fellingham Aug 1990 A
4959050 Bobo, Jr. Sep 1990 A
4966579 Polaschegg Oct 1990 A
4968941 Rogers Nov 1990 A
4972842 Korten et al. Nov 1990 A
4976687 Martin Dec 1990 A
4978335 Arthur, III Dec 1990 A
4979940 Lapp et al. Dec 1990 A
4981467 Bobo et al. Jan 1991 A
5000663 Gorton Mar 1991 A
5000739 Kulisz et al. Mar 1991 A
5006050 Cooke et al. Apr 1991 A
5010473 Jacobs Apr 1991 A
5014714 Millay et al. May 1991 A
5014798 Glynn May 1991 A
5018945 D'Silva May 1991 A
5026348 Venegas Jun 1991 A
5028857 Taghezout Jul 1991 A
5032112 Fairchild et al. Jul 1991 A
5034004 Crankshaw Jul 1991 A
5035143 Latimer et al. Jul 1991 A
5040699 Gangemi Aug 1991 A
5041086 Koenig et al. Aug 1991 A
5043706 Oliver Aug 1991 A
5045069 Imparato Sep 1991 A
5049047 Polaschegg et al. Sep 1991 A
5052230 Lang Oct 1991 A
5053747 Slate et al. Oct 1991 A
5055761 Mills Oct 1991 A
5056992 Simons Oct 1991 A
5058161 Weiss Oct 1991 A
5059171 Bridge Oct 1991 A
5063603 Burt Nov 1991 A
5064412 Henke et al. Nov 1991 A
5078683 Sancoff et al. Jan 1992 A
5084663 Olsson Jan 1992 A
5084828 Kaufman et al. Jan 1992 A
5088981 Howson et al. Feb 1992 A
5096385 Georgi et al. Mar 1992 A
5097505 Weiss Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5102392 Sakai et al. Apr 1992 A
5103211 Daoud et al. Apr 1992 A
5104374 Bishko et al. Apr 1992 A
5108367 Epstein et al. Apr 1992 A
5109850 Blanco et al. May 1992 A
5116203 Nartwick et al. May 1992 A
5116312 Blakenship et al. May 1992 A
5116316 Sertic May 1992 A
5123275 Daoud et al. Jun 1992 A
5124627 Okada Jun 1992 A
5125499 Saathoff et al. Jun 1992 A
5131816 Brown Jul 1992 A
5132603 Yoshimoto Jul 1992 A
5153827 Coutre et al. Oct 1992 A
5158441 Aid Oct 1992 A
5161222 Montejo et al. Nov 1992 A
5174472 Raque et al. Dec 1992 A
5176631 Koenig Jan 1993 A
5176646 Kuroda Jan 1993 A
5179340 Rogers Jan 1993 A
5180287 Natwick et al. Jan 1993 A
5181910 Scanlon Jan 1993 A
5186057 Everhart Feb 1993 A
5188603 Vaillancourt Feb 1993 A
5190522 Wocicki et al. Mar 1993 A
5191795 Fellingham et al. Mar 1993 A
5192340 Grant et al. Mar 1993 A
5194796 Domeki et al. Mar 1993 A
5198776 Carr Mar 1993 A
5200090 Ford Apr 1993 A
5205819 Ross et al. Apr 1993 A
5206522 Danby et al. Apr 1993 A
5207642 Orkin et al. May 1993 A
5211626 Frank et al. May 1993 A
5213573 Sorich et al. May 1993 A
5215450 Tamari Jun 1993 A
5216597 Beckers Jun 1993 A
5219099 Spence et al. Jun 1993 A
5219327 Okada Jun 1993 A
5221268 Barton et al. Jun 1993 A
5229713 Bullock et al. Jul 1993 A
5232476 Grant Aug 1993 A
5233571 Wirtschafter Aug 1993 A
5237309 Frantz et al. Aug 1993 A
5242406 Gross et al. Sep 1993 A
5242408 Jhuboo et al. Sep 1993 A
5243982 Möstl et al. Sep 1993 A
5244463 Cordner, Jr. et al. Sep 1993 A
5244568 Lindsay et al. Sep 1993 A
5254096 Rondelet et al. Oct 1993 A
5256155 Yerlikaya et al. Oct 1993 A
5256156 Kern et al. Oct 1993 A
5256157 Samiotes et al. Oct 1993 A
5260665 Goldberg Nov 1993 A
5257206 Hanson Dec 1993 A
5267980 Dirr et al. Dec 1993 A
5274316 Evans et al. Dec 1993 A
5276610 Maeda et al. Jan 1994 A
5280728 Sato et al. Jan 1994 A
5283510 Tamaki et al. Feb 1994 A
5287851 Beran et al. Feb 1994 A
5292306 Wynkoop et al. Mar 1994 A
5295967 Rondelet et al. Mar 1994 A
5298021 Sherer Mar 1994 A
5303585 Lichte Apr 1994 A
5304126 Epstein et al. Apr 1994 A
5304216 Wallace Apr 1994 A
5308333 Skakoon May 1994 A
5317506 Coutre et al. May 1994 A
5319363 Welch et al. Jun 1994 A
5319979 Abrahamson Jun 1994 A
5321392 Skakoon et al. Jun 1994 A
5325170 Bornhop Jun 1994 A
5325728 Zimmerman et al. Jul 1994 A
5328460 Lord et al. Jul 1994 A
5330634 Wong et al. Jul 1994 A
5333497 Braend et al. Aug 1994 A
5336051 Tamari Aug 1994 A
5338157 Blomquist Aug 1994 A
5342298 Michaels Aug 1994 A
5343734 Maeda et al. Sep 1994 A
5343885 Grant Sep 1994 A
5346466 Yerlikaya et al. Sep 1994 A
5356378 Doan et al. Oct 1994 A
5359271 Husher Oct 1994 A
5364346 Schrezenmeir Nov 1994 A
5366346 Danby Nov 1994 A
5368562 Blomquist et al. Nov 1994 A
5374865 Yoshimura et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5378231 Johnson et al. Jan 1995 A
5382232 Hague et al. Jan 1995 A
5383369 Khuri-Yakub et al. Jan 1995 A
5389071 Kawahara et al. Feb 1995 A
5389078 Zalesky et al. Feb 1995 A
5392638 Kawahara Feb 1995 A
5394732 Johnson et al. Mar 1995 A
5395320 Padda et al. Mar 1995 A
5399171 Bowman et al. Mar 1995 A
5406954 Tomita Apr 1995 A
5408326 Priestley Apr 1995 A
5415528 Ogden et al. May 1995 A
5417119 Smoll May 1995 A
5417222 Dempsey et al. May 1995 A
5417395 Fowler et al. May 1995 A
5418443 Kikuchi May 1995 A
5421208 Packard et al. Jun 1995 A
5423748 Uhala Jun 1995 A
5423749 Merte et al. Jun 1995 A
5423759 Campbell Jun 1995 A
5428284 Kaneda et al. Jun 1995 A
5429485 Dodge Jul 1995 A
5429601 Conley Jul 1995 A
5429602 Hauser Jul 1995 A
5431627 Pastrone et al. Jul 1995 A
5434508 Ishida Jul 1995 A
5437624 Langley et al. Aug 1995 A
5444316 Ohya et al. Aug 1995 A
5444378 Rogers Aug 1995 A
5445621 Poli et al. Aug 1995 A
5450758 Smoll Sep 1995 A
5451881 Finger Sep 1995 A
5455423 Mount et al. Oct 1995 A
5455851 Chaco et al. Oct 1995 A
5463906 Spani et al. Nov 1995 A
5464392 Epstein et al. Nov 1995 A
5465082 Chaco Nov 1995 A
5469851 Lipschutz Nov 1995 A
5473948 Moss et al. Dec 1995 A
5480294 Di Perna et al. Jan 1996 A
5482438 Anderson et al. Jan 1996 A
5485408 Blomquist Jan 1996 A
5486286 Peterson et al. Jan 1996 A
5489265 Montalvo et al. Feb 1996 A
5495566 Kwatinetz Feb 1996 A
5496273 Pastrone et al. Mar 1996 A
5505696 Miki Apr 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5507412 Ebert et al. Apr 1996 A
5520637 Pager et al. May 1996 A
5522798 Johnson et al. Jun 1996 A
5522799 Furukawa Jun 1996 A
5527630 Nagata Jun 1996 A
5533389 Kamen et al. Jul 1996 A
5537853 Finburgh et al. Jul 1996 A
5542040 Chang et al. Jul 1996 A
5545140 Conero et al. Aug 1996 A
5547470 Johnson et al. Aug 1996 A
5551850 Williamson et al. Sep 1996 A
5554013 Owens et al. Sep 1996 A
5554115 Thomas et al. Sep 1996 A
5558638 Evers et al. Sep 1996 A
5562615 Nassif Oct 1996 A
5563486 Yamamoto et al. Oct 1996 A
5572105 Nojima et al. Nov 1996 A
5573502 LeCocq et al. Nov 1996 A
5583280 Mo et al. Dec 1996 A
5584667 Davis Dec 1996 A
5584806 Amano Dec 1996 A
5586868 Lawless et al. Dec 1996 A
5590653 Aida et al. Jan 1997 A
5594786 Chaco et al. Jan 1997 A
5600073 Hill Feb 1997 A
5601420 Warner et al. Feb 1997 A
5609575 Larson et al. Mar 1997 A
5609576 Voss Mar 1997 A
5611784 Barresi et al. Mar 1997 A
5616124 Hague et al. Apr 1997 A
5620312 Hyman et al. Apr 1997 A
5620608 Rosa et al. Apr 1997 A
5626140 Feldman et al. May 1997 A
5626151 Linden May 1997 A
5626563 Dodge et al. May 1997 A
5627443 Kimura et al. May 1997 A
5628309 Brown May 1997 A
5628731 Dodge et al. May 1997 A
5630710 Tune et al. May 1997 A
5634896 Bryant et al. Jun 1997 A
5637095 Nason et al. Jun 1997 A
5640075 Brasseur et al. Jun 1997 A
5640150 Atwater Jun 1997 A
5643212 Coutre et al. Jul 1997 A
5648710 Ikeda Jul 1997 A
5649536 Ogura et al. Jul 1997 A
5651775 Walker et al. Jul 1997 A
5657000 Ellingboe Aug 1997 A
5658133 Anderson et al. Aug 1997 A
5658250 Blomquist et al. Aug 1997 A
5659234 Cresens Aug 1997 A
5661245 Svoboda et al. Aug 1997 A
5662612 Niehoff Sep 1997 A
5665065 Colman et al. Sep 1997 A
5669877 Blomquist Sep 1997 A
5672154 Sillén et al. Sep 1997 A
5672832 Cucci et al. Sep 1997 A
5681285 Ford et al. Oct 1997 A
5681286 Niehoff Oct 1997 A
5685844 Marttila Nov 1997 A
5685866 Lopez Nov 1997 A
5687717 Halpern et al. Nov 1997 A
5689229 Chaco et al. Nov 1997 A
5691613 Gutwillinger Nov 1997 A
5695464 Viallet Dec 1997 A
5695473 Olsen Dec 1997 A
5697899 Hillman et al. Dec 1997 A
5697916 Schraga Dec 1997 A
5712795 Layman et al. Jan 1998 A
5713856 Eggers et al. Feb 1998 A
5714691 Hill Feb 1998 A
5718562 Lawless et al. Feb 1998 A
5718569 Holst Feb 1998 A
5720721 Dumas et al. Feb 1998 A
5722417 Rudolph Mar 1998 A
5728074 Castellano et al. Mar 1998 A
5728948 Bignell et al. Mar 1998 A
5733257 Stemby Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5734464 Gibbs Mar 1998 A
5738659 Neer et al. Apr 1998 A
5743856 Oka et al. Apr 1998 A
5744027 Connell et al. Apr 1998 A
5744929 Miyazaki Apr 1998 A
5745378 Barker et al. Apr 1998 A
5752813 Tyner et al. May 1998 A
5752918 Fowler et al. May 1998 A
5752919 Schrimpf May 1998 A
5755691 Hilborne May 1998 A
5758643 Wong et al. Jun 1998 A
5761072 Bardsley, Jr. et al. Jun 1998 A
5764034 Bowman et al. Jun 1998 A
5766155 Hyman et al. Jun 1998 A
5772635 Dastur et al. Jun 1998 A
5778256 Darbee Jul 1998 A
5781442 Engleson et al. Jul 1998 A
5782805 Meinzer et al. Jul 1998 A
5788669 Peterson Aug 1998 A
5788674 McWilliams Aug 1998 A
5789923 Shimoyama et al. Aug 1998 A
5792069 Greenwald et al. Aug 1998 A
5793211 Shimoyama et al. Aug 1998 A
5795327 Wilson et al. Aug 1998 A
5798934 Saigo et al. Aug 1998 A
5800387 Duffy et al. Sep 1998 A
5803712 Davis et al. Sep 1998 A
5803917 Butterfield Sep 1998 A
5805455 Lipps Sep 1998 A
5807322 Lindsey et al. Sep 1998 A
5810770 Chin et al. Sep 1998 A
5813972 Nazarian et al. Sep 1998 A
5814004 Tamari Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5816779 Lawless et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5827179 Lichter et al. Oct 1998 A
5827223 Butterfield Oct 1998 A
5832448 Brown Nov 1998 A
5836910 Duffy et al. Nov 1998 A
5841261 Nojima et al. Nov 1998 A
5841284 Takahashi Nov 1998 A
5843035 Bowman Dec 1998 A
5848971 Fowler et al. Dec 1998 A
5850344 Conkright Dec 1998 A
5857843 Leason et al. Jan 1999 A
5864330 Haynes Jan 1999 A
5865805 Ziemba Feb 1999 A
5867821 Ballantyne et al. Feb 1999 A
5871465 Vasko Feb 1999 A
5872453 Shimoyama et al. Feb 1999 A
5875195 Dixon Feb 1999 A
5882300 Malinouskas et al. Mar 1999 A
5882339 Beiser et al. Mar 1999 A
5885245 Lynch et al. Mar 1999 A
5889379 Yanagi et al. Mar 1999 A
5891051 Han et al. Apr 1999 A
5894209 Takagi et al. Apr 1999 A
5897493 Brown Apr 1999 A
5897498 Canfield, II et al. Apr 1999 A
5898292 Takemoto et al. Apr 1999 A
5899665 Makino et al. May 1999 A
5901150 Jhuboo et al. May 1999 A
5904666 DeDecker et al. May 1999 A
5904668 Hyman et al. May 1999 A
5905207 Schalk May 1999 A
5906598 Giesier May 1999 A
5910252 Truitt et al. Jun 1999 A
5915240 Karpf Jun 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5923159 Ezell Jul 1999 A
5924074 Evans Jul 1999 A
5927349 Martucci Jul 1999 A
5932119 Kaplan et al. Aug 1999 A
5932987 McLoughlin Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5935106 Olsen Aug 1999 A
5938634 Packard Aug 1999 A
5938636 Kramer et al. Aug 1999 A
5941846 Duffy et al. Aug 1999 A
5944660 Kimball et al. Aug 1999 A
5947911 Wong et al. Sep 1999 A
5954527 Jhuboo et al. Sep 1999 A
5954696 Ryan et al. Sep 1999 A
5956023 Lyle et al. Sep 1999 A
5956501 Brown Sep 1999 A
5957885 Bollish et al. Sep 1999 A
5957890 Mann et al. Sep 1999 A
5971594 Sahai et al. Oct 1999 A
5973497 Bergk et al. Oct 1999 A
5975081 Hood et al. Nov 1999 A
5989222 Cole et al. Nov 1999 A
5990838 Burns et al. Nov 1999 A
5991525 Shah et al. Nov 1999 A
5993393 Ryan et al. Nov 1999 A
5994876 Canny et al. Nov 1999 A
5997476 Brown Dec 1999 A
6000828 Leet Dec 1999 A
6003006 Colella et al. Dec 1999 A
6003388 Oeftering Dec 1999 A
6012034 Hamparian et al. Jan 2000 A
6017318 Gauthier et al. Jan 2000 A
6017493 Cambron Jan 2000 A
6021392 Lester et al. Feb 2000 A
6023977 Langdon et al. Feb 2000 A
6024539 Blomquist Feb 2000 A
6027441 Cantu Feb 2000 A
6028412 Shine et al. Feb 2000 A
6032676 Moore Mar 2000 A
6033561 Schoendorfer Mar 2000 A
6036017 Bayliss, IV Mar 2000 A
6068612 Bowman May 2000 A
6068615 Brown et al. May 2000 A
6073106 Rozen et al. Jun 2000 A
6077246 Kullas et al. Jun 2000 A
6083206 Molko Jul 2000 A
6089104 Chang Jul 2000 A
6104295 Gaisser et al. Aug 2000 A
6110152 Kovelman Aug 2000 A
6110153 Davis Aug 2000 A
6120459 Nitzan et al. Sep 2000 A
6122536 Sun et al. Sep 2000 A
6142008 Cole et al. Nov 2000 A
6150942 O'Brien Nov 2000 A
6157914 Seto et al. Dec 2000 A
6158288 Smith Dec 2000 A
6158965 Butterfield et al. Dec 2000 A
6159147 Lichter et al. Dec 2000 A
6159186 Wickham et al. Dec 2000 A
6164921 Moubayed et al. Dec 2000 A
6168561 Cantu Jan 2001 B1
6178827 Feller Jan 2001 B1
6182667 Hanks et al. Feb 2001 B1
6186141 Pike et al. Feb 2001 B1
6189105 Lopes Feb 2001 B1
6192752 Blaine Feb 2001 B1
6195589 Ketcham Feb 2001 B1
6202711 Martucci Mar 2001 B1
6203528 Deckert Mar 2001 B1
6208107 Maske et al. Mar 2001 B1
6212936 Meisberger Apr 2001 B1
6213972 Butterfield Apr 2001 B1
6231320 Lawless et al. May 2001 B1
6234176 Domae et al. May 2001 B1
6236326 Murphy et al. May 2001 B1
6237398 Porat et al. May 2001 B1
6241704 Peterson et al. Jun 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6250132 Drzewiecki Jun 2001 B1
6259355 Chaco et al. Jul 2001 B1
6259587 Sheldon et al. Jul 2001 B1
6261065 Nayak Jul 2001 B1
6262946 Khuri-Yakub et al. Jul 2001 B1
6267559 Mossman et al. Jul 2001 B1
6267725 Dubberstein et al. Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6271813 Palalau Aug 2001 B1
6277072 Bardy Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6280380 Bardy Aug 2001 B1
6280391 Olson et al. Aug 2001 B1
6280408 Sipin Aug 2001 B1
6283761 Joao Sep 2001 B1
6285155 Maske et al. Sep 2001 B1
6312378 Bardy Nov 2001 B1
6322516 Masuda et al. Nov 2001 B1
6330351 Yasunaga Dec 2001 B1
6337675 Toffolo et al. Jan 2002 B1
6345539 Rawes et al. Feb 2002 B1
6347553 Morris et al. Feb 2002 B1
6349740 Cho et al. Feb 2002 B1
6358225 Butterfield Mar 2002 B1
6358387 Kopf-Sill et al. Mar 2002 B1
6362591 Moberg Mar 2002 B1
6385505 Lipps May 2002 B1
6386050 Yin et al. May 2002 B1
6394958 Bratteli et al. May 2002 B1
6396583 Clare May 2002 B1
6398760 Danby Jun 2002 B1
6405076 Taylor et al. Jun 2002 B1
6408679 Kline-Schoder et al. Jun 2002 B1
6413238 Maget Jul 2002 B1
6416291 Butterfield et al. Jul 2002 B1
6418334 Unger et al. Jul 2002 B1
6418535 Kulakowski et al. Jul 2002 B1
6445053 Cho Sep 2002 B1
6456245 Crawford Sep 2002 B1
6457346 Kline-Schoder et al. Oct 2002 B1
6463785 Kline-Schoder et al. Oct 2002 B1
6467331 Kline-Schoder et al. Oct 2002 B1
6468242 Wilson et al. Oct 2002 B1
6475178 Krajewski Nov 2002 B1
6481980 Vandlik Nov 2002 B1
6482158 Mault Nov 2002 B2
6482185 Hartmann Nov 2002 B1
6485263 Bryant et al. Nov 2002 B1
6485418 Yasushi et al. Nov 2002 B2
6485465 Moberg et al. Nov 2002 B2
6487916 Gomm et al. Dec 2002 B1
6489896 Platt Dec 2002 B1
6494694 Lawless et al. Dec 2002 B2
6494831 Koritzinsky Dec 2002 B1
6497680 Holst et al. Dec 2002 B1
6503221 Briggs Jan 2003 B1
6512944 Kovtun et al. Jan 2003 B1
6516667 Broad et al. Feb 2003 B1
6517482 Eiden et al. Feb 2003 B1
6519569 White et al. Feb 2003 B1
6529751 Van Driel et al. Mar 2003 B1
6531708 Malmstrom Mar 2003 B1
6539315 Adams et al. Mar 2003 B1
6540672 Simonsen et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6544228 Heitmeier Apr 2003 B1
6558125 Futterknecht May 2003 B1
6558351 Steil et al. May 2003 B1
6562012 Brown et al. May 2003 B1
6564825 Lowery et al. May 2003 B2
6565509 Say et al. May 2003 B1
6568416 Tucker et al. May 2003 B2
6572542 Houben et al. Jun 2003 B1
6572545 Knobbe et al. Jun 2003 B2
6572576 Brugger et al. Jun 2003 B2
6578422 Lam et al. Jun 2003 B2
6578435 Gould et al. Jun 2003 B2
6581117 Klein et al. Jun 2003 B1
6585675 O'Mahony et al. Jul 2003 B1
6589229 Connelly et al. Jul 2003 B1
6589792 Malachowski Jul 2003 B1
6599281 Struys et al. Jul 2003 B1
6599282 Burko Jul 2003 B2
6602191 Quy Aug 2003 B2
6605072 Struys et al. Aug 2003 B2
6606047 Börjesson et al. Aug 2003 B1
6609047 Lipps Aug 2003 B1
6615674 Ohnishi Sep 2003 B2
6616633 Butterfield et al. Sep 2003 B1
6617564 Ockerse et al. Sep 2003 B2
6618916 Eberle et al. Sep 2003 B1
6622542 Derek Sep 2003 B2
6622561 Lam et al. Sep 2003 B2
6629449 Kline-Schoder et al. Oct 2003 B1
6634233 He Oct 2003 B2
6640246 Gardy, Jr. et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6641541 Lovett et al. Nov 2003 B1
6648861 Platt et al. Nov 2003 B2
6652455 Kocher Nov 2003 B1
6653937 Nelson et al. Nov 2003 B2
6659980 Moberg et al. Dec 2003 B2
6685668 Cho et al. Feb 2004 B1
6685678 Evans et al. Feb 2004 B2
6689069 Bratteli et al. Feb 2004 B2
6689091 Bui et al. Feb 2004 B2
6692241 Watanabe et al. Feb 2004 B2
6716004 Vandlik Apr 2004 B2
6719535 Rakestraw et al. Apr 2004 B2
6721582 Trepagnier et al. Apr 2004 B2
6722211 Ciobanu et al. Apr 2004 B1
6725200 Rost Apr 2004 B1
6725721 Venczel Apr 2004 B2
6731989 Engleson et al. May 2004 B2
6732595 Lynnworth May 2004 B2
6738052 Manke et al. May 2004 B1
6740072 Starkweather et al. May 2004 B2
6741212 Kralovec et al. May 2004 B2
6748808 Lam et al. Jun 2004 B2
6749403 Bryant et al. Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6753842 Williams et al. Jun 2004 B1
6759007 Westberg Jul 2004 B1
6760643 Lipps Jul 2004 B2
6768920 Lange Jul 2004 B2
6773412 O'Mahony Aug 2004 B2
6780156 Haueter et al. Aug 2004 B2
6783328 Lucke et al. Aug 2004 B2
6785573 Kovtun et al. Aug 2004 B2
6786885 Hochman et al. Sep 2004 B2
6789426 Yaralioglu et al. Sep 2004 B2
6790198 White et al. Sep 2004 B1
6793625 Cavallaro et al. Sep 2004 B2
6801227 Bocionek et al. Oct 2004 B2
6805671 Stergiopoulos et al. Oct 2004 B2
6807965 Hickle Oct 2004 B1
6809653 Mann et al. Oct 2004 B1
6813964 Clark et al. Nov 2004 B1
6814547 Childers Nov 2004 B2
6824528 Faries Nov 2004 B1
6830558 Flaherty et al. Dec 2004 B2
6840113 Fukumura et al. Jan 2005 B2
6846161 Kline Jan 2005 B2
6852094 Beck Feb 2005 B2
6852104 Blomquist Feb 2005 B2
6854338 Khuri-Yakub et al. Feb 2005 B2
6857318 Silber et al. Feb 2005 B1
6869425 Briggs et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6883376 He Apr 2005 B2
6885881 Leonhardt Apr 2005 B2
6887216 Hochman et al. May 2005 B2
6898301 Iwanaga May 2005 B2
6907361 Molenaar Jun 2005 B2
6907792 Ohnishi Jun 2005 B2
6915170 Engleson et al. Jul 2005 B2
6920795 Bischoff et al. Jul 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6928338 Buchser et al. Aug 2005 B1
6929619 Fago et al. Aug 2005 B2
6929751 Bowman Aug 2005 B2
6932114 Sparks Aug 2005 B2
6932796 Sage et al. Aug 2005 B2
6935192 Sobek et al. Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6941005 Lary et al. Sep 2005 B2
6942636 Holst et al. Sep 2005 B2
6945954 Hochman et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6964204 Clark et al. Nov 2005 B2
6973374 Ader Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6975922 Duncan et al. Dec 2005 B2
6978779 Haveri et al. Dec 2005 B2
6979326 Mann et al. Dec 2005 B2
6981960 Cho et al. Jan 2006 B2
6984218 Nayak et al. Jan 2006 B2
6985768 Hemming et al. Jan 2006 B2
6985870 Martucci et al. Jan 2006 B2
6986347 Hickle Jan 2006 B2
6986753 Bui Jan 2006 B2
6997905 Gillespie, Jr. et al. Feb 2006 B2
6997920 Mann et al. Feb 2006 B2
7006005 Nazarian et al. Feb 2006 B2
7017623 Tribble et al. Mar 2006 B2
7021148 Kuhn Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7029455 Flaherty Apr 2006 B2
7029456 Ware et al. Apr 2006 B2
7059184 Kanouda et al. Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7069793 Ishikawa et al. Jul 2006 B2
7072725 Bristol et al. Jul 2006 B2
7074209 Evans et al. Jul 2006 B2
7080557 Adnan Jul 2006 B2
7082843 Clark et al. Aug 2006 B2
7087444 Wong et al. Aug 2006 B2
7092796 Vanderveen Aug 2006 B2
7092797 Gaines et al. Aug 2006 B2
7093502 Kupnik et al. Aug 2006 B2
7096729 Repko et al. Aug 2006 B2
7103419 Engleson et al. Sep 2006 B2
7104763 Bouton et al. Sep 2006 B2
7104769 Davis Sep 2006 B2
7108680 Rohr et al. Sep 2006 B2
7109878 Mann et al. Sep 2006 B2
7115113 Evans et al. Oct 2006 B2
7117041 Engleson et al. Oct 2006 B2
7137964 Flaherty Nov 2006 B2
7141037 Butterfield et al. Nov 2006 B2
7152490 Freund, Jr. et al. Dec 2006 B1
7154397 Zerhusen et al. Dec 2006 B2
7161488 Frasch Jan 2007 B2
7162290 Levin Jan 2007 B1
7162927 Selvan et al. Jan 2007 B1
7171277 Engleson et al. Jan 2007 B2
7171992 DiGianfilippo Feb 2007 B2
7174789 Orr et al. Feb 2007 B2
7185288 McKeever Feb 2007 B2
7197943 Lee et al. Apr 2007 B2
7201734 Hickle Apr 2007 B2
7204823 Estes et al. Apr 2007 B2
7206715 Vanderveen et al. Apr 2007 B2
7213009 Pestotnik May 2007 B2
7220240 Struys et al. May 2007 B2
7229430 Hickle et al. Jun 2007 B2
7230529 Ketcherside Jun 2007 B2
7232430 Carlisle Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7247154 Hickle Jul 2007 B2
7253779 Greer et al. Aug 2007 B2
7254425 Lowery et al. Aug 2007 B2
7258534 Fathallah et al. Aug 2007 B2
7267664 Rizzo Sep 2007 B2
7267665 Steil et al. Sep 2007 B2
7272529 Hogan et al. Sep 2007 B2
7278983 Ireland et al. Oct 2007 B2
7291123 Baraldi et al. Nov 2007 B2
7293461 Gimdt Nov 2007 B1
7294109 Lovett et al. Nov 2007 B2
7296482 Schaffer et al. Nov 2007 B2
7300418 Zaleski Nov 2007 B2
7305883 Khuri-Yakub et al. Dec 2007 B2
7327273 Hung et al. Feb 2008 B2
7338470 Katz Mar 2008 B2
7343224 DiGianfilippo Mar 2008 B2
7347836 Peterson et al. Mar 2008 B2
7347854 Shelton et al. Mar 2008 B2
7354420 Steil et al. Apr 2008 B2
7356382 Vanderveen Apr 2008 B2
7360999 Nelson et al. Apr 2008 B2
7364562 Braig et al. Apr 2008 B2
7367942 Grage et al. May 2008 B2
7369948 Ferenczi et al. May 2008 B1
7384410 Eggers et al. Jun 2008 B2
7397166 Morgan et al. Jul 2008 B1
7398183 Holland et al. Jul 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7402154 Mendez Jul 2008 B2
7407489 Mendez Aug 2008 B2
7414534 Kroll et al. Aug 2008 B1
7415895 Kurisaki et al. Aug 2008 B2
7426443 Simon Sep 2008 B2
7430675 Lee et al. Sep 2008 B2
7447566 Knauper et al. Nov 2008 B2
7447643 Olson Nov 2008 B1
7452190 Bouton et al. Nov 2008 B2
7454314 Holland et al. Nov 2008 B2
7471994 Ford et al. Dec 2008 B2
7477997 Kaplit Jan 2009 B2
7482818 Greenwald et al. Jan 2009 B2
7483756 Engleson et al. Jan 2009 B2
7490021 Holland et al. Feb 2009 B2
7491187 Van Den Berghe et al. Feb 2009 B2
7503903 Carlisle et al. Mar 2009 B2
7517332 Tonelli et al. Apr 2009 B2
7523401 Aldridge Apr 2009 B1
7545075 Huang et al. Jun 2009 B2
7556616 Fathallah et al. Jul 2009 B2
7561986 Vanderveen et al. Jul 2009 B2
7571024 Duncan et al. Aug 2009 B2
7605730 Tomioka et al. Oct 2009 B2
7645258 White et al. Jan 2010 B2
7654127 Krulevitch et al. Feb 2010 B2
7657443 Crass Feb 2010 B2
7668731 Martucci et al. Feb 2010 B2
7678048 Urbano et al. Mar 2010 B1
7693697 Westenskow et al. Apr 2010 B2
7699806 Ware et al. Apr 2010 B2
7705727 Pestotnik Apr 2010 B2
7766873 Moberg et al. Aug 2010 B2
7775126 Eckhardt Aug 2010 B2
7775127 Wade Aug 2010 B2
7785284 Baralsi et al. Aug 2010 B2
7785313 Mastrototaro Aug 2010 B2
7786909 Udupa et al. Aug 2010 B2
7806886 Kanderian, Jr. et al. Oct 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7847276 Carlisle Dec 2010 B2
7860583 Condurso et al. Dec 2010 B2
7871394 Halbert et al. Jan 2011 B2
7876443 Bernacki Jan 2011 B2
7895053 Holland et al. Feb 2011 B2
7895882 Carlisle Mar 2011 B2
7896834 Smisson, III Mar 2011 B2
7896842 Palmroos et al. Mar 2011 B2
7905710 Wang et al. Mar 2011 B2
7933780 de la Huerga Apr 2011 B2
7945452 Fathallah et al. May 2011 B2
7976508 Hoag Jul 2011 B2
7981073 Mollstam Jul 2011 B2
7981082 Wang et al. Jul 2011 B2
7998134 Fangrow Aug 2011 B2
8002736 Patrick et al. Aug 2011 B2
8034020 Dewey Oct 2011 B2
8038593 Friedman et al. Oct 2011 B2
8065161 Howard et al. Nov 2011 B2
8067760 Carlisle Nov 2011 B2
8075514 Butterfield et al. Dec 2011 B2
8075546 Carlisle et al. Dec 2011 B2
8078983 Davis et al. Dec 2011 B2
8121857 Galasso et al. Feb 2012 B2
8149131 Blomquist Apr 2012 B2
8175668 Nabutovsky et al. May 2012 B1
8177739 Cartledge et al. May 2012 B2
8180440 McCombie et al. May 2012 B2
8185322 Schroeder et al. May 2012 B2
8197444 Bazargan et al. Jun 2012 B1
8219413 Martinez et al. Jul 2012 B2
8221395 Shelton et al. Jul 2012 B2
8226597 Jacobson et al. Jul 2012 B2
8231578 Fathallah et al. Jul 2012 B2
8234128 Martucci et al. Jul 2012 B2
8271106 Wehba et al. Sep 2012 B2
8287514 Miller et al. Oct 2012 B2
8291337 Gannin et al. Oct 2012 B2
8313308 Lawless et al. Nov 2012 B2
8317698 Lowery Nov 2012 B2
8317750 Ware et al. Nov 2012 B2
8317752 Cozmi et al. Nov 2012 B2
8318094 Bayandorian et al. Nov 2012 B1
8340792 Condurso et al. Dec 2012 B2
8347731 Genosar Jan 2013 B2
8359338 Butterfield et al. Jan 2013 B2
8361021 Wang et al. Jan 2013 B2
8378837 Wang et al. Feb 2013 B2
8388598 Steinkogler Mar 2013 B2
8398616 Budiman Mar 2013 B2
8403908 Jacobson et al. Mar 2013 B2
8409164 Fangrow Apr 2013 B2
8449524 Braig et al. May 2013 B2
8469942 Kow et al. Jun 2013 B2
8477307 Yufa et al. Jul 2013 B1
8494879 Davis et al. Jul 2013 B2
8504179 Blomquist Aug 2013 B2
8517990 Teel et al. Aug 2013 B2
8518021 Stewart et al. Aug 2013 B2
8522832 Lopez et al. Sep 2013 B2
8523797 Lowery et al. Sep 2013 B2
8539812 Stringham et al. Sep 2013 B2
8543416 Palmroos et al. Sep 2013 B2
8577692 Silkaitis et al. Nov 2013 B2
8622990 Estes et al. Jan 2014 B2
8630722 Condurso et al. Jan 2014 B2
8665214 Forutanpour et al. Mar 2014 B2
8666769 Butler et al. Mar 2014 B2
8700421 Feng et al. Apr 2014 B2
8706233 Su et al. Apr 2014 B2
8721584 Braithwaite et al. May 2014 B2
8728020 Caleffi et al. May 2014 B2
8758306 Lopez et al. Jun 2014 B2
8761906 Condurso et al. Jun 2014 B2
8768719 Wehba et al. Jul 2014 B2
8771251 Ruchti et al. Jul 2014 B2
8792981 Yudovsky et al. Jul 2014 B2
8821432 Unverdorben Sep 2014 B2
8823382 Rondoni et al. Sep 2014 B2
8857269 Johnson et al. Oct 2014 B2
8858185 Johnson et al. Oct 2014 B2
8905965 Mandro et al. Dec 2014 B2
8964185 Luo et al. Feb 2015 B1
9005150 Ware et al. Apr 2015 B2
9026370 Rubalcaba et al. May 2015 B2
9084855 Ware et al. Jul 2015 B2
9114217 Sur et al. Aug 2015 B2
9134735 Lowery et al. Sep 2015 B2
9134736 Lowery et al. Sep 2015 B2
9138526 Ware et al. Sep 2015 B2
9190010 Vik et al. Nov 2015 B2
9240002 Hume et al. Jan 2016 B2
9272089 Jacobson et al. Mar 2016 B2
9333291 Jacobson et al. May 2016 B2
9381296 Arrizza et al. Jul 2016 B2
9393362 Cozmi et al. Jul 2016 B2
9468718 Hung et al. Oct 2016 B2
9498583 Sur et al. Nov 2016 B2
9545475 Borges et al. Jan 2017 B2
9707341 Dumas, III et al. Jul 2017 B2
9764087 Peterfreund et al. Sep 2017 B2
9852265 Treacy et al. Dec 2017 B1
9883987 Lopez et al. Feb 2018 B2
9943269 Muhsin et al. Apr 2018 B2
9995611 Ruchti et al. Jun 2018 B2
10022498 Ruchti et al. Jul 2018 B2
10046112 Oruklu et al. Aug 2018 B2
10089055 Fryman Oct 2018 B1
10099009 Anderson et al. Oct 2018 B1
10166328 Oruklu et al. Jan 2019 B2
10342917 Shubinsky et al. Jul 2019 B2
10430761 Hume et al. Oct 2019 B2
10463788 Day Nov 2019 B2
10549248 Brown et al. Feb 2020 B2
10578474 Ruchti et al. Mar 2020 B2
10596316 Dumas, III et al. Mar 2020 B2
10635784 Rubalcaba, Jr. et al. Apr 2020 B2
10656894 Fryman May 2020 B2
10682102 Declerck Jun 2020 B2
10709885 Janders Jul 2020 B2
10850024 Day et al. Dec 2020 B2
10874793 Oruklu et al. Dec 2020 B2
11004035 Hume et al. May 2021 B2
11029911 Fryman Jun 2021 B2
11090431 Dumas, III et al. Aug 2021 B2
11135360 Jacobson et al. Oct 2021 B1
11439570 Lopez Sep 2022 B2
20010007636 Butterfield Jul 2001 A1
20010014769 Bufe et al. Aug 2001 A1
20010015099 Blaine Aug 2001 A1
20010016056 Westphal et al. Aug 2001 A1
20010032099 Joao Oct 2001 A1
20010037060 Thompson et al. Nov 2001 A1
20010041869 Causey et al. Nov 2001 A1
20010044731 Coffman et al. Nov 2001 A1
20020003892 Iwanaga Jan 2002 A1
20020007116 Zatezalo et al. Jan 2002 A1
20020013545 Soltanpour et al. Jan 2002 A1
20020013551 Zaitsu et al. Jan 2002 A1
20020015018 Shimazu et al. Feb 2002 A1
20020018720 Carlisle et al. Feb 2002 A1
20020029776 Blomquist Mar 2002 A1
20020031838 Meinhart et al. Mar 2002 A1
20020032583 Joao Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020044059 Reeder et al. Apr 2002 A1
20020045806 Baker, Jr. et al. Apr 2002 A1
20020082728 Mueller et al. Jun 2002 A1
20020083771 Khuri-Yakub et al. Jul 2002 A1
20020085952 Ellingboe et al. Jul 2002 A1
20020087115 Hartlaub Jul 2002 A1
20020095486 Bahl Jul 2002 A1
20020099282 Knobbe et al. Jul 2002 A1
20020099334 Hanson et al. Jul 2002 A1
20020143580 Bristol et al. Oct 2002 A1
20020147389 Cavallaro et al. Oct 2002 A1
20020152239 Bautista-Lloyd et al. Oct 2002 A1
20020168278 Jeon et al. Nov 2002 A1
20020173703 Lebel et al. Nov 2002 A1
20020183693 Peterson et al. Dec 2002 A1
20030009244 Engleson Jan 2003 A1
20030013959 Grunwald et al. Jan 2003 A1
20030018289 Ng et al. Jan 2003 A1
20030018308 Tsai Jan 2003 A1
20030025602 Medema et al. Feb 2003 A1
20030028082 Thompson Feb 2003 A1
20030030001 Cooper et al. Feb 2003 A1
20030045840 Burko Mar 2003 A1
20030050621 Lebel et al. Mar 2003 A1
20030060688 Ciarniello et al. Mar 2003 A1
20030060765 Campbell et al. Mar 2003 A1
20030065537 Evans Apr 2003 A1
20030065589 Giacchetti Apr 2003 A1
20030073954 Moberg et al. Apr 2003 A1
20030079746 Hickle May 2003 A1
20030083583 Kovtun et al. May 2003 A1
20030091442 Bush et al. May 2003 A1
20030104982 Wittmann et al. Jun 2003 A1
20030106553 Vanderveen Jun 2003 A1
20030125662 Bui Jul 2003 A1
20030130616 Steil Jul 2003 A1
20030135087 Hickle et al. Jul 2003 A1
20030136193 Fujimoto Jul 2003 A1
20030139701 White et al. Jul 2003 A1
20030140928 Bui et al. Jul 2003 A1
20030141981 Bui et al. Jul 2003 A1
20030143746 Sage, Jr. Jul 2003 A1
20030144878 Wilkes et al. Jul 2003 A1
20030158508 DiGianfilippo Aug 2003 A1
20030160683 Blomquist Aug 2003 A1
20030163789 Blomquist Aug 2003 A1
20030173408 Mosher, Jr. et al. Sep 2003 A1
20030186833 Huff et al. Oct 2003 A1
20030187338 Say et al. Oct 2003 A1
20030200116 Forrester Oct 2003 A1
20030204274 Ullestad et al. Oct 2003 A1
20030204416 Acharya Oct 2003 A1
20030212364 Mann et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216682 Junker Nov 2003 A1
20030217962 Childers et al. Nov 2003 A1
20030233071 Gillespie, Jr. et al. Dec 2003 A1
20040030277 O'Mahony et al. Feb 2004 A1
20040047736 Nose et al. Mar 2004 A1
20040057226 Berthou et al. Mar 2004 A1
20040064342 Browne et al. Apr 2004 A1
20040073125 Lovett et al. Apr 2004 A1
20040073161 Tachibana Apr 2004 A1
20040077996 Jasperson et al. Apr 2004 A1
20040082908 Whitehurst Apr 2004 A1
20040082918 Evans et al. Apr 2004 A1
20040104271 Martucci et al. Jun 2004 A1
20040119753 Zencke Jun 2004 A1
20040120825 Bouton et al. Jun 2004 A1
20040128162 Schlotterbeck et al. Jul 2004 A1
20040128163 Goodman et al. Jul 2004 A1
20040133166 Moberg et al. Jul 2004 A1
20040145114 Ippolito et al. Jul 2004 A1
20040147034 Gore et al. Jul 2004 A1
20040149823 Aptekar Aug 2004 A1
20040152970 Hunter et al. Aug 2004 A1
20040158193 Bui et al. Aug 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040167465 Kohler Aug 2004 A1
20040167804 Simpson Aug 2004 A1
20040172222 Simpson et al. Sep 2004 A1
20040172283 Vanderveen Sep 2004 A1
20040172289 Kozic et al. Sep 2004 A1
20040172302 Martucci et al. Sep 2004 A1
20040176984 White et al. Sep 2004 A1
20040181314 Zaleski Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193325 Bonderud Sep 2004 A1
20040193328 Butterfield et al. Sep 2004 A1
20040204638 Diab et al. Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040220517 Starkweather et al. Nov 2004 A1
20040225252 Gillespie et al. Nov 2004 A1
20040225409 Duncan et al. Nov 2004 A1
20040232219 Fowler Nov 2004 A1
20040253123 Xie et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040254513 Shang et al. Dec 2004 A1
20050021006 Tonnies Jan 2005 A1
20050021297 Hartlaub Jan 2005 A1
20050022274 Campbell et al. Jan 2005 A1
20050038680 McMahon Feb 2005 A1
20050055242 Bello et al. Mar 2005 A1
20050055244 Mullan et al. Mar 2005 A1
20050065465 Lebel et al. Mar 2005 A1
20050075544 Shapiro et al. Apr 2005 A1
20050096593 Pope et al. May 2005 A1
20050099624 Staehr May 2005 A1
20050107923 Vanderveen May 2005 A1
20050108057 Cohen et al. May 2005 A1
20050119597 O'Mahony et al. Jun 2005 A1
20050119914 Batch Jun 2005 A1
20050131739 Rabinowitz et al. Jun 2005 A1
20050137522 Aoki Jun 2005 A1
20050143864 Blomquist Jun 2005 A1
20050145010 Vanderveen et al. Jul 2005 A1
20050171503 Van Den Berghe et al. Aug 2005 A1
20050171815 Vanderveen Aug 2005 A1
20050177045 Degertekin et al. Aug 2005 A1
20050177096 Bollish et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050182355 Bui Aug 2005 A1
20050182366 Vogt et al. Aug 2005 A1
20050187515 Varrichio et al. Aug 2005 A1
20050192529 Butterfield et al. Sep 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050197554 Polcha Sep 2005 A1
20050197621 Poulsen et al. Sep 2005 A1
20050197649 Shelton et al. Sep 2005 A1
20050209563 Hopping et al. Sep 2005 A1
20050209793 Yamada Sep 2005 A1
20050224083 Crass Oct 2005 A1
20050235732 Rush Oct 2005 A1
20050238506 Mescher et al. Oct 2005 A1
20050240305 Bogash et al. Oct 2005 A1
20050273059 Mernoe et al. Dec 2005 A1
20050277890 Stewart et al. Dec 2005 A1
20050279419 Tribble et al. Dec 2005 A1
20060002799 Schann et al. Jan 2006 A1
20060009727 O'Mahony et al. Jan 2006 A1
20060009734 Martin Jan 2006 A1
20060042633 Bishop et al. Mar 2006 A1
20060047270 Shelton Mar 2006 A1
20060053036 Coffman et al. Mar 2006 A1
20060064020 Burnes et al. Mar 2006 A1
20060064053 Bollish et al. Mar 2006 A1
20060079768 Small et al. Apr 2006 A1
20060079831 Gilbert Apr 2006 A1
20060100746 Leibner-Druska May 2006 A1
20060100907 Holland et al. May 2006 A1
20060106649 Eggers et al. May 2006 A1
20060116639 Russell Jun 2006 A1
20060117856 Orr et al. Jun 2006 A1
20060117867 Froehlich et al. Jun 2006 A1
20060122867 Eggers et al. Jun 2006 A1
20060135939 Brown Jun 2006 A1
20060135940 Joshi Jun 2006 A1
20060136095 Rob et al. Jun 2006 A1
20060136271 Eggers et al. Jun 2006 A1
20060140798 Kutsuzawa Jun 2006 A1
20060143051 Eggers et al. Jun 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060180916 Wyland Aug 2006 A1
20060181695 Sage, Jr. Aug 2006 A1
20060187069 Duan Aug 2006 A1
20060190302 Eggers et al. Aug 2006 A1
20060195022 Trepagnier et al. Aug 2006 A1
20060200007 Brockway et al. Sep 2006 A1
20060200369 Batch et al. Sep 2006 A1
20060211404 Cromp et al. Sep 2006 A1
20060224140 Junker Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060224181 McEwen et al. Oct 2006 A1
20060226088 Robinson et al. Oct 2006 A1
20060226089 Robinson et al. Oct 2006 A1
20060226090 Robinson et al. Oct 2006 A1
20060229918 Fotsch et al. Oct 2006 A1
20060235353 Gelfand et al. Oct 2006 A1
20060255149 Retter et al. Nov 2006 A1
20060258985 Russell Nov 2006 A1
20060260416 Sage et al. Nov 2006 A1
20060264895 Flanders Nov 2006 A1
20060266128 Clark et al. Nov 2006 A1
20060270971 Gelfand et al. Nov 2006 A1
20060271286 Rosenberg Nov 2006 A1
20060272421 Frinak et al. Dec 2006 A1
20060275142 Bouton et al. Dec 2006 A1
20070015972 Wang et al. Jan 2007 A1
20070036511 Lundquist et al. Feb 2007 A1
20070060796 Kim Mar 2007 A1
20070060871 Istoc Mar 2007 A1
20070060872 Hall et al. Mar 2007 A1
20070060874 Nesbitt et al. Mar 2007 A1
20070062250 Krulevitch et al. Mar 2007 A1
20070065363 Dalal et al. Mar 2007 A1
20070078314 Grounsell Apr 2007 A1
20070083152 Williams, Jr. et al. Apr 2007 A1
20070084288 Thomas et al. Apr 2007 A1
20070088271 Richards Apr 2007 A1
20070088333 Levin et al. Apr 2007 A1
20070093753 Krulevitcvh et al. Apr 2007 A1
20070094045 Cobbs et al. Apr 2007 A1
20070100222 Mastrototaro et al. May 2007 A1
20070100665 Brown May 2007 A1
20070112298 Mueller et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070129618 Goldberger et al. Jun 2007 A1
20070142822 Remde Jun 2007 A1
20070156452 Batch Jul 2007 A1
20070179436 Braig et al. Aug 2007 A1
20070191817 Martin Aug 2007 A1
20070214003 Holland et al. Sep 2007 A1
20070215545 Bissler et al. Sep 2007 A1
20070233035 Wehba et al. Oct 2007 A1
20070233049 Wehba et al. Oct 2007 A1
20070240497 Robinson et al. Oct 2007 A1
20070250339 Mallett et al. Oct 2007 A1
20070255250 Moberg et al. Nov 2007 A1
20070257788 Carlson Nov 2007 A1
20070267945 Sudol Nov 2007 A1
20070270747 Remde Nov 2007 A1
20070274843 Vanderveen et al. Nov 2007 A1
20070289384 Sakai et al. Dec 2007 A1
20080009684 Corsetti et al. Jan 2008 A1
20080028868 Konzelmann et al. Feb 2008 A1
20080033361 Evans et al. Feb 2008 A1
20080039777 Katz et al. Feb 2008 A1
20080048211 Khuri-Yakub et al. Feb 2008 A1
20080058773 John Mar 2008 A1
20080060448 Wiest et al. Mar 2008 A1
20080065420 Tirinato et al. Mar 2008 A1
20080071210 Moubayed et al. Mar 2008 A1
20080071496 Glascock Mar 2008 A1
20080071580 Marcus et al. Mar 2008 A1
20080077116 Dailey et al. Mar 2008 A1
20080091466 Butler et al. Apr 2008 A1
20080097288 Levin et al. Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080097317 Alholm et al. Apr 2008 A1
20080098798 Riley et al. May 2008 A1
20080119822 Knauper May 2008 A1
20080125701 Moberg et al. May 2008 A1
20080139907 Rao et al. Jun 2008 A1
20080145249 Smisson Jun 2008 A1
20080169044 Osborne et al. Jul 2008 A1
20080172030 Blomquist et al. Jul 2008 A1
20080177254 Shelton et al. Jul 2008 A1
20080184784 Dam Aug 2008 A1
20080188789 Galavotti et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080208484 Butterfield et al. Aug 2008 A1
20080214919 Harmon et al. Sep 2008 A1
20080221521 Getz et al. Sep 2008 A1
20080221522 Moberg et al. Sep 2008 A1
20080262469 Bristol et al. Oct 2008 A1
20080269663 Arnold et al. Oct 2008 A1
20080269714 Mastrototaro et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080275384 Mastrototaro et al. Nov 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20090001908 Shubinsky et al. Jan 2009 A1
20090005703 Fasciano Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006129 Thukral Jan 2009 A1
20090006133 Weinert Jan 2009 A1
20090015824 Shubinsky et al. Jan 2009 A1
20090043171 Rule Feb 2009 A1
20090054743 Stewart Feb 2009 A1
20090054754 McMahon et al. Feb 2009 A1
20090069743 Krishnamoorthy et al. Mar 2009 A1
20090077248 Castellucci et al. Mar 2009 A1
20090082676 Bennison Mar 2009 A1
20090088731 Campbell et al. Apr 2009 A1
20090097029 Tokhtuev et al. Apr 2009 A1
20090099866 Newman Apr 2009 A1
20090105636 Hayter et al. Apr 2009 A1
20090112155 Zhao Apr 2009 A1
20090114037 Smith May 2009 A1
20090119330 Sampath et al. May 2009 A1
20090124963 Hogard et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090126825 Eliuk et al. May 2009 A1
20090131861 Braig et al. May 2009 A1
20090135196 Holland et al. May 2009 A1
20090143726 Bouton et al. Jun 2009 A1
20090144025 Bouton et al. Jun 2009 A1
20090144026 Bouton et al. Jun 2009 A1
20090149743 Barron et al. Jun 2009 A1
20090156922 Goldberger et al. Jun 2009 A1
20090156975 Robinson et al. Jun 2009 A1
20090177146 Nesbitt et al. Jul 2009 A1
20090177188 Steinkogler Jul 2009 A1
20090177248 Roberts Jul 2009 A1
20090177769 Roberts Jul 2009 A1
20090178485 Thomas et al. Jul 2009 A1
20090183147 Davis et al. Jul 2009 A1
20090192367 Braig et al. Jul 2009 A1
20090205426 Balschat et al. Aug 2009 A1
20090209938 Aalto-Setala Aug 2009 A1
20090209945 Lobl et al. Aug 2009 A1
20090212966 Panduro Aug 2009 A1
20090221890 Saffer et al. Sep 2009 A1
20090223294 Thomas et al. Sep 2009 A1
20090227939 Memoe et al. Sep 2009 A1
20090264720 Torjman et al. Oct 2009 A1
20090270810 DeBelser Oct 2009 A1
20090270833 DeBelser Oct 2009 A1
20100022988 Wochner Jan 2010 A1
20100280430 Caleffi et al. Jan 2010 A1
20100036310 Hillman Feb 2010 A1
20100056992 Hayter Mar 2010 A1
20100057042 Hayter Mar 2010 A1
20100069892 Steinbach et al. Mar 2010 A1
20100077866 Graboi et al. Apr 2010 A1
20100079760 Bernacki Apr 2010 A1
20100094251 Estes et al. Apr 2010 A1
20100106082 Zhou Apr 2010 A1
20100114027 Jacobson et al. May 2010 A1
20100121170 Rule May 2010 A1
20100121415 Skelton et al. May 2010 A1
20100130933 Holland et al. May 2010 A1
20100131434 Magent et al. May 2010 A1
20100141460 Tokhtuev et al. Jun 2010 A1
20100147081 Thomas et al. Jun 2010 A1
20100152554 Steine et al. Jun 2010 A1
20100160854 Gauthier Jun 2010 A1
20100168535 Robinson et al. Jul 2010 A1
20100177375 Seyfried Jul 2010 A1
20100185142 Kamen et al. Jul 2010 A1
20100185182 Alme et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198182 Lanigan et al. Aug 2010 A1
20100198183 Lanigan et al. Aug 2010 A1
20100211002 Davis Aug 2010 A1
20100212407 Stringham et al. Aug 2010 A1
20100212675 Walling et al. Aug 2010 A1
20100217154 Deshmukh et al. Aug 2010 A1
20100217621 Schoenberg Aug 2010 A1
20100271218 Hoag et al. Oct 2010 A1
20100271479 Heydlauf Oct 2010 A1
20100273738 Valcke et al. Oct 2010 A1
20100292634 Kircher Nov 2010 A1
20100295686 Sloan et al. Nov 2010 A1
20100298765 Budiman et al. Nov 2010 A1
20100312039 Quirico et al. Dec 2010 A1
20100317093 Turewicz et al. Dec 2010 A1
20100317952 Budiman et al. Dec 2010 A1
20100318025 John Dec 2010 A1
20110000560 Miller et al. Jan 2011 A1
20110001605 Kiani et al. Jan 2011 A1
20110004186 Butterfield Jan 2011 A1
20110009797 Kelly et al. Jan 2011 A1
20110028885 Eggers et al. Feb 2011 A1
20110046558 Gravesen et al. Feb 2011 A1
20110062703 Lopez et al. Mar 2011 A1
20110064612 Franzoni et al. Mar 2011 A1
20110071464 Palerm Mar 2011 A1
20110071844 Cannon et al. Mar 2011 A1
20110072379 Gannon Mar 2011 A1
20110077480 Bloom et al. Mar 2011 A1
20110078608 Gannon et al. Mar 2011 A1
20110099313 Bolanowski Apr 2011 A1
20110105983 Kelly et al. May 2011 A1
20110106561 Eaton, Jr. et al. May 2011 A1
20110107251 Guaitoli et al. May 2011 A1
20110137241 DelCastilio et al. Jun 2011 A1
20110144595 Cheng Jun 2011 A1
20110152770 Diperna et al. Jun 2011 A1
20110160649 Pan Jun 2011 A1
20110162647 Huby et al. Jul 2011 A1
20110172918 Tome Jul 2011 A1
20110175728 Baker, Jr. Jul 2011 A1
20110190598 Shusterman Aug 2011 A1
20110190694 Lanier et al. Aug 2011 A1
20110218514 Rebours Sep 2011 A1
20110264006 Ali et al. Oct 2011 A1
20110264043 Kotnick et al. Oct 2011 A1
20110282321 Steil et al. Nov 2011 A1
20110313390 Roy et al. Dec 2011 A1
20110319728 Petisce et al. Dec 2011 A1
20110320049 Chossat et al. Dec 2011 A1
20120025995 Moberg et al. Feb 2012 A1
20120059234 Barrett et al. Mar 2012 A1
20120068001 Pushkarsky et al. Mar 2012 A1
20120083760 Ledford et al. Apr 2012 A1
20120089411 Srnka et al. Apr 2012 A1
20120095433 Hungerford et al. Apr 2012 A1
20120123322 Scarpaci et al. May 2012 A1
20120143116 Ware et al. Jun 2012 A1
20120180790 Montgomery Jul 2012 A1
20120185267 Kamen et al. Jul 2012 A1
20120191059 Cummings et al. Jul 2012 A1
20120194341 Peichel et al. Aug 2012 A1
20120203177 Lanier Aug 2012 A1
20120222774 Husnu et al. Sep 2012 A1
20120226350 Rudser et al. Sep 2012 A1
20120245525 Pope et al. Sep 2012 A1
20120259278 Hayes et al. Oct 2012 A1
20120310204 Krogh et al. Dec 2012 A1
20120323212 Murphy Dec 2012 A1
20130006666 Schneider Jan 2013 A1
20130009551 Knapp Jan 2013 A1
20130012880 Blomquist Jan 2013 A1
20130012917 Miller et al. Jan 2013 A1
20130032634 McKirdy Feb 2013 A1
20130041342 Bernini et al. Feb 2013 A1
20130044111 VanGilder et al. Feb 2013 A1
20130110538 Butterfield et al. May 2013 A1
20130150766 Olde et al. Jun 2013 A1
20130150821 Bollish et al. Jun 2013 A1
20130197930 Garibaldi et al. Aug 2013 A1
20130201482 Munro Aug 2013 A1
20130116649 Kouyoumjian et al. Sep 2013 A1
20130253430 Kouyoumjian et al. Sep 2013 A1
20130274576 Amirouche et al. Oct 2013 A1
20130281965 Kamen et al. Oct 2013 A1
20130291116 Homer Oct 2013 A1
20130296823 Melker et al. Nov 2013 A1
20130296984 Burnett et al. Nov 2013 A1
20130318158 Teng et al. Nov 2013 A1
20130345658 Browne et al. Dec 2013 A1
20130345666 Panduro et al. Dec 2013 A1
20140067425 Dudar et al. Mar 2014 A1
20140145915 Ribble et al. May 2014 A1
20140180711 Kamen et al. Jun 2014 A1
20140224829 Capone et al. Aug 2014 A1
20140267563 Baca et al. Sep 2014 A1
20140303591 Peterfreund et al. Oct 2014 A1
20150025453 Ledford et al. Jan 2015 A1
20150033073 Yang et al. Jan 2015 A1
20150065988 Holderle et al. Mar 2015 A1
20150114515 Phallen Apr 2015 A1
20150168958 Downie et al. Jun 2015 A1
20150265765 Yavorsky et al. Sep 2015 A1
20150338340 Jiang et al. Nov 2015 A1
20150343141 Lindo et al. Dec 2015 A1
20150371004 Jones Dec 2015 A1
20160042264 Borges et al. Feb 2016 A1
20160110088 Vik et al. Apr 2016 A1
20160144101 Pananen May 2016 A1
20160151560 Toro et al. Jun 2016 A1
20160151562 Magers et al. Jun 2016 A1
20160151601 Cardelius et al. Jun 2016 A1
20160158437 Biasi et al. Jun 2016 A1
20160175517 Sileika et al. Jun 2016 A1
20160193604 McFarland et al. Jul 2016 A1
20160339167 Ledford et al. Nov 2016 A1
20170043089 Handler Feb 2017 A1
20170354941 Brown et al. Dec 2017 A1
20180018440 Sugawara Jan 2018 A1
20190091401 Ruchti et al. Mar 2019 A1
20190262535 Shubinsky et al. Aug 2019 A1
20190269846 Oruklu et al. Sep 2019 A1
20190282757 Gylland et al. Sep 2019 A1
20200069864 Shubinsky et al. Mar 2020 A1
20200113784 Lopez Apr 2020 A1
20200238007 Day Jul 2020 A1
20200271499 Ruchti et al. Aug 2020 A1
20200282137 Dumas, III et al. Sep 2020 A1
20200324044 Gylland et al. Oct 2020 A1
20200357500 Rubalcaba, Jr. et al. Nov 2020 A1
20210170101 Cavendish, Jr. et al. Jun 2021 A1
20210260283 Oruklu et al. Aug 2021 A1
20210295263 Hume et al. Sep 2021 A1
20210397396 Fryman Dec 2021 A1
Foreign Referenced Citations (177)
Number Date Country
2013216679 Sep 2013 AU
PI0704229-9 Nov 2009 BR
2 113 473 Mar 1993 CA
2 551 817 Jul 2005 CA
31 12 762 Jan 1983 DE
34 35 647 Jul 1985 DE
35 30 747 Mar 1987 DE
37 20 664 Jan 1989 DE
38 27 444 Feb 1990 DE
197 34 002 Sep 1998 DE
199 01 078 Feb 2000 DE
198 40 965 Mar 2000 DE
198 44 252 Mar 2000 DE
199 32 147 Jan 2001 DE
102 49 238 May 2004 DE
103 52 456 Jul 2005 DE
0 282 323 Sep 1988 EP
0 291 727 Nov 1988 EP
0 319 272 Jun 1989 EP
0 319 275 Jun 1989 EP
0 335 385 Oct 1989 EP
0 337 092 Oct 1989 EP
0 341 582 Nov 1989 EP
0 370 162 May 1990 EP
0 387 724 Sep 1990 EP
0 429 866 Jun 1991 EP
0 441 323 Aug 1991 EP
0 453 211 Oct 1991 EP
0 462 405 Dec 1991 EP
0 501 234 Sep 1992 EP
0 516 130 Dec 1992 EP
0 519 765 Dec 1992 EP
0 643 301 Mar 1995 EP
0 683 465 Nov 1995 EP
0 431 310 Jan 1996 EP
0 589 439 Aug 1998 EP
0 880 936 Dec 1998 EP
0 954 090 Nov 1999 EP
0 960 627 Dec 1999 EP
1 174 817 Jan 2002 EP
1 177 802 Feb 2002 EP
1 197 178 Apr 2002 EP
1 500 025 Apr 2003 EP
1 813 188 Aug 2007 EP
1 490 131 Dec 2007 EP
2 062 527 May 2009 EP
2 228 004 Sep 2010 EP
2 243 506 Oct 2010 EP
2 381 260 Oct 2011 EP
254513 Oct 1981 ES
2 717 919 Sep 1995 FR
2 121 971 Jan 1984 GB
2 303 706 Feb 1997 GB
2 312 022 Oct 1997 GB
2 312 046 Oct 1997 GB
01-301118 Dec 1989 JP
01-308568 Dec 1989 JP
04-231966 Aug 1992 JP
07-502678 Mar 1995 JP
07-289638 Nov 1995 JP
11-128344 May 1999 JP
2000-111374 Apr 2000 JP
2000-510575 Aug 2000 JP
2000-515716 Nov 2000 JP
2001-356034 Dec 2001 JP
2002-506514 Feb 2002 JP
2002-131105 May 2002 JP
2003-038642 Feb 2003 JP
2003-050144 Feb 2003 JP
2005-021463 Jan 2005 JP
2005-524081 Mar 2005 JP
2006-517423 Jul 2006 JP
2007-071695 Mar 2007 JP
2007-518471 Jul 2007 JP
2007-520270 Jul 2007 JP
2007-275106 Oct 2007 JP
2008-249400 Oct 2008 JP
4322661 Jun 2009 JP
2010-063767 Mar 2010 JP
WO 84000690 Mar 1984 WO
WO 84000894 Mar 1984 WO
WO 90007942 Jul 1990 WO
WO 91000113 Jan 1991 WO
WO 91016087 Oct 1991 WO
WO 91016416 Oct 1991 WO
WO 93004284 Mar 1993 WO
WO 95016200 Jun 1995 WO
WO 95031233 Nov 1995 WO
WO 96008755 Mar 1996 WO
WO 96025186 Aug 1996 WO
WO 96028209 Sep 1996 WO
WO 96041156 Dec 1996 WO
WO 97010013 Mar 1997 WO
WO 97030333 Aug 1997 WO
WO 98004304 Feb 1998 WO
WO 98012670 Mar 1998 WO
WO 98014234 Apr 1998 WO
WO 98019263 May 1998 WO
WO 98044320 Oct 1998 WO
WO 98056441 Dec 1998 WO
WO 99015216 Apr 1999 WO
WO 99051003 Oct 1999 WO
WO 99052575 Oct 1999 WO
WO 00013580 Mar 2000 WO
WO 00013726 Mar 2000 WO
WO 00041621 Jul 2000 WO
WO 01014974 Mar 2001 WO
WO 01033484 May 2001 WO
WO 02005702 Jan 2002 WO
WO 02009795 Feb 2002 WO
WO 02027276 Apr 2002 WO
WO 02066101 Aug 2002 WO
WO 02087664 Nov 2002 WO
WO 03006091 Jan 2003 WO
WO 03053498 Jul 2003 WO
WO 03093780 Nov 2003 WO
WO 2004035115 Apr 2004 WO
WO 2004060455 Jul 2004 WO
WO 2004070556 Aug 2004 WO
WO 2004070994 Aug 2004 WO
WO 2004112579 Dec 2004 WO
WO 2005018716 Mar 2005 WO
WO 2005030489 Apr 2005 WO
WO 2005036447 Apr 2005 WO
WO 2005057175 Jun 2005 WO
WO 2005065146 Jul 2005 WO
WO 2005065749 Jul 2005 WO
WO 2005082450 Sep 2005 WO
WO 2005118015 Dec 2005 WO
WO 2006016122 Feb 2006 WO
WO 2006022906 Mar 2006 WO
WO 2007000426 Jan 2007 WO
WO 2007033025 Mar 2007 WO
WO 2007035567 Mar 2007 WO
WO 2007087443 Aug 2007 WO
WO 2008004560 Jan 2008 WO
WO 2008019016 Feb 2008 WO
WO 2008053193 May 2008 WO
WO 2008059492 May 2008 WO
WO 2008063429 May 2008 WO
WO 2008067245 Jun 2008 WO
WO 2008088490 Jul 2008 WO
WO 2008134146 Nov 2008 WO
WO 2009016504 Feb 2009 WO
WO 2009023406 Feb 2009 WO
WO 2009023407 Feb 2009 WO
WO 2009023634 Feb 2009 WO
WO 2009039203 Mar 2009 WO
WO 2009039214 Mar 2009 WO
WO 2009049252 Apr 2009 WO
WO 2009127683 Oct 2009 WO
WO 2009141504 Nov 2009 WO
WO 2010017279 Feb 2010 WO
WO 2010075371 Jul 2010 WO
WO 2010099313 Sep 2010 WO
WO 2010114929 Oct 2010 WO
WO 2010119409 Oct 2010 WO
WO 2010124127 Oct 2010 WO
WO 2010135646 Nov 2010 WO
WO 2010135654 Nov 2010 WO
WO 2010135670 Nov 2010 WO
WO 2010135686 Nov 2010 WO
WO 2010148205 Dec 2010 WO
WO 2011017778 Feb 2011 WO
WO 2011080188 Jul 2011 WO
WO 2011109774 Sep 2011 WO
WO 2012042763 Apr 2012 WO
WO 2012082599 Jun 2012 WO
WO 2012108910 Aug 2012 WO
WO 2012167090 Dec 2012 WO
WO 2013036854 Mar 2013 WO
WO 2013096769 Jun 2013 WO
WO 2015134478 Sep 2015 WO
WO 2017051271 Mar 2017 WO
WO 2017144366 Aug 2017 WO
WO 2019092680 May 2019 WO
WO 2020214717 Oct 2020 WO
Non-Patent Literature Citations (58)
Entry
Alaedeen et al., “Total Parenteral Nutrition-Associated Hyperglycemia Correlates with Prolonged Mechanical Ventilation and Hospital Stay in Septic Infants”, Journal of Pediatric Surgery, Jan. 2006, vol. 41, No. 1, pp. 239-244.
Alaris® Medical Systems, “Signature Edition® Gold—Single & Dual Channel Infusion System”, San Diego, CA, USA, date unknown, but believed to be at least as early as Nov. 29, 2008, pp. 2-88 & 2-91.
Allegro, “3955—Full-Bridge PWM Microstepping Motor Drive”, Datasheet, 1997, pp. 16.
Aragon, Daleen RN, Ph.D., CCRN, “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377.
Baxter, “Baxter Receives 510(k) Clearance for Next-Generation SIGMA Spectrum Infusion Pump with Master Drug Library” Press Release, May 8, 2014, pp. 2. http://web.archive.org/web/20160403140025/http://www.baxter.com/news-media/newsroom/press-releases/2014/05_08_14_sigma.page.
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47.
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824.
Binder et al., “Insulin Infusion with Parenteral Nutrition in Extremely Low Birth Weight Infants with Hyperglycemia”, Journal of Pediatrics, Feb. 1989, vol. 114, No. 2, pp. 273-280.
Bode et al., “Intravenous Insulin Infusion Therapy: Indications, Methods, and Transition to Subcutaneous Insulin Therapy”, Endocrine Practice, Mar./Apr. 2004, vol. 10, Supplement 2, pp. 71-80.
Buhrdorf et al., “Capacitive Micromachined Ultrasonic Transducers and their Application”, Proceedings of the IEEE Ultrasonics Symposium, Feb. 2001, vol. 2, pp. 933-940.
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756.
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, https://store.cerner.com/items/7.
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572.
Cheung et al., “Hyperglycemia is Associated with Adverse Outcomes in Patients Receiving Total Parenteral Nutrition”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2367-2371.
Coley et al., “Performance of Three Portable Infusion-Pump Devices Set to Deliver 2 mL/hr”, American Journal of Health-System Pharmacy, Jun. 1, 1997, vol. 54, No. 11, pp. 1277-1280.
“Continually vs Continuously”, https://web.archive.org/web/20090813092423/http://www.diffen.com/difference/Continually_vs_Continuously, as accessed Aug. 13, 2009 in 4 pages.
“CritiCore® Monitor: Critical Fluid Output and Core Bladder Temperature Monitor”, BARD Urological Catheter Systems, Advertisement, 2005, pp. 2.
Daimiwal et al., “Wireless Transfusion Supervision and Analysis Using Embedded System”, IEEE, 2010 International Conference ICBBT, China, Apr. 2010, pp. 56-60.
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423.
“Decision of the Administrative Council of Oct. 16, 2013 Amending Rule 135 and 164 of the Implementing Regulations to the European Patent Convention (CA/D 17/13)”, Official Journal EPO dated Nov. 2013, dated Nov. 2013, pp. 503-506. http://archive.epo.org/epo/pubs/oj013/11_13/11_5033.pdf.
“Decision of the Administrative Council of Oct. 27, 2009 Amending the Implementing Regulations to the European Patent Convention (CA/D 20/09)”, Official Journal EPO dated Dec. 2009, dated Dec. 2009, pp. 582-584. http://archive.epo.org/epo/pubs/oj009/12_09/12_5829.pdf.
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32.
“Differential Pressure Transmitter, Series PD-39 X”, SensorsOne Ltd., Advertisement, Dec. 2005, pp. 2.
Dunster et al., “Flow Continuity of Infusion Systems at Low Flow Rates”, Anaesthesia and Intensive Care, Oct. 1995, vol. 23, No. 5, pp. 5.
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®), Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372.
“Froth”, http://www.merriam-webster.com/dictionary/froth, as accessed May 13, 2015 in 1 page.
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically Ill Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191.
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attributable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112.
Hospira, “Plum A+™ Infusion System” as archived Dec. 1, 2012, pp. 2. www.hospira.com/products_and_services/infusion_pumps/plum/index.
Hospira, “Plum XL™ Series Infusion System” Technical Service Manual, Feb. 2005, Lake Forest, Illinois, USA, pp. i-vii, 5-14, 8-3.
Ilfeld et al., “Delivery Rate Accuracy of Portable, Bolus-Capable Infusion Pumps Used for Patient-Controlled Continuous Regional Analgesia”, Regional Anesthesia and Pain Medicine, Jan.-Feb. 2003, vol. 28, No. 1, pp. 17-23.
Ilfeld et al., “Portable Infusion Pumps Used for Continuous Regional Analgesia: Delivery Rate Accuracy and Consistency”, Regional Anesthesia and Pain Medicine, Sep.-Oct. 2003, vol. 28, No. 5, pp. 424-432.
International Search Report and Written Opinion received in PCT Application No. PCT Application No. PCT/US2021/041891, dated Oct. 26, 2021 in 10 pages.
JMS Co., Ltd., “Infusion Pump: OT-701”, Tokyo, Japan, 2002, pp. 4.
Kim, M.D., et al., “Hyperglycemia Control of the Nil Per Os Patient in the Intensive Care Unit: Introduction of a Simple Subcutaneous Insulin Algorithm”, Nov. 2012, Journal of Diabetes Science and Technology, vol. 6, No. 6, pp. 1413-1419.
Kutcher et al., “The Effect of Lighting Conditions on Caries Interpretation with a Laptop Computer in a Clinical Setting”, Elsevier, Oct. 2006, vol. 102, No. 4, pp. 537-543.
Lamsdale et al., “A Usability Evaluation of an Infusion Pump by Nurses Using a Patient Simulator”, Proceedings of the Human Factors and Ergonomics Society 49th Annual Meeting, Sep. 2005, pp. 1024-1028.
Logan et al., “Fabricating Capacitive Micromachined Ultrasonic Transducers with a Novel Silicon-Nitride-Based Wafer Bonding Process”, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, May 2009, vol. 56, No. 5, pp. 1074-1084.
Magaji et al., “Inpatient Management of Hyperglycemia and Diabetes”, Clinical Diabetes, 2011, vol. 29, No. 1, pp. 3-9.
Mauseth et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922.
Maynard et al., “Subcutaneous Insulin Order Sets and Protocols: Effective Design and Implementation Strategies”, Journal of Hospital Medicine, Sep./Oct. 2008, vol. 3, Issue 5, Supplement 5, pp. S29-S41.
Merry et al., “A New, Safety-Oriented, Integrated Drug Administration and Automated Anesthesia Record System”, Anesthesia & Analgesia, Aug. 2001, vol. 93, No. 2 pp. 385-390.
Microchip Technology Inc., “MTA11200B; TrueGauge™ Intelligent Battery Management I.C.”, https://www.elektronik.ropla.eu/pdf/stock/mcp/mta11200b.pdf, 1995, pp. 44.
Moghissi, Etie, MD, FACP, Face, “Hyperglycemia in Hospitalized Patients”, A Supplement to ACP Hospitalist, Jun. 15, 2008, pp. 32.
Nuckols et al., “Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events”, Journal of General Internal Medicine, 2007, vol. 23, Supp. 1, pp. 41-45.
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24.
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006.
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904.
SGS—Thomson Microelectronics, “L6219—Stepper Motor Drive”, Datasheet, Dec. 1996, pp. 10.
SGS—Thomson Microelectronics, “PBL3717A—Stepper Motor Drive”, Datasheet, Apr. 1993, pp. 11.
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36.
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2.
Tang et al., “Linear Dimensionality Reduction Using Relevance Weighted LDA”, Pattern Recognition, 2005, vol. 38, pp. 485-493, http://staff.ustc.edu.cn/˜ketang/papers/TangSuganYaoQin_PR04.pdf.
Thomas et al., “Implementation of a Tight Glycaemic Control Protocol Using a Web-Based Insulin Dose Calculator”, Anaesthesia, 2005, vol. 60, pp. 1093-1100.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically Ill Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461.
Westbrook et al., “Errors in the Administration of Intravenous Medications in Hospital and the Role of Correct Procedures and Nurse Experience”, BMJ Quality & Safety, 2011, vol. 20, pp. 1027-1034.
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely Ill Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512.
Related Publications (1)
Number Date Country
20220142865 A1 May 2022 US
Provisional Applications (1)
Number Date Country
63054568 Jul 2020 US
Continuations (1)
Number Date Country
Parent PCT/US2021/041891 Jul 2021 US
Child 17648657 US